Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Journal of Epidemiology
Published in: European Journal of Epidemiology 8/2015

Open Access 01-08-2015 | STUDY UPDATE

The Rotterdam Study: 2016 objectives and design update

Authors: Albert Hofman, Guy G. O. Brusselle, Sarwa Darwish Murad, Cornelia M. van Duijn, Oscar H. Franco, André Goedegebure, M. Arfan Ikram, Caroline C. W. Klaver, Tamar E. C. Nijsten, Robin P. Peeters, Bruno H. Ch. Stricker, Henning W. Tiemeier, André G. Uitterlinden, Meike W. Vernooij

Published in: European Journal of Epidemiology | Issue 8/2015

Login to get access

Abstract

The Rotterdam Study is a prospective cohort study ongoing since 1990 in the city of Rotterdam in The Netherlands. The study targets cardiovascular, endocrine, hepatic, neurological, ophthalmic, psychiatric, dermatological, otolaryngological, locomotor, and respiratory diseases. As of 2008, 14,926 subjects aged 45 years or over comprise the Rotterdam Study cohort. The findings of the Rotterdam Study have been presented in over 1200 research articles and reports (see www.​erasmus-epidemiology.​nl/​rotterdamstudy). This article gives the rationale of the study and its design. It also presents a summary of the major findings and an update of the objectives and methods.
Literature
1.
Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science. 2002;296(5570):1029–31.PubMedCrossRef
2.
3.
Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol. 1991;7(4):403–22.PubMedCrossRef
4.
Hofman A, Breteler MM, van Duijn CM, Krestin GP, Pols HA, Stricker BH, et al. The Rotterdam Study: objectives and design update. Eur J Epidemiol. 2007;22(11):819–29.PubMedCentralPubMedCrossRef
5.
Hofman A, van Duijn CM, Franco OH, Ikram MA, Janssen HL, Klaver CC, et al. The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol. 2011;26(8):657–86.PubMedCentralPubMedCrossRef
6.
Webber L, Mytton OT, Briggs ADM, Woodcock J, Scarborough P, McPherson K, et al. The Brighton declaration: the value of non-communicable disease modelling in population health sciences. Eur J Epidemiol. 2014;29(12):867–70.PubMedCentralPubMedCrossRef
7.
Kruithof CJ, Kooijman MN, van Duijn CM, Franco OH, de Jongste JC, Klaver CCW, et al. The Generation R Study: biobank update 2015. Eur J Epidemiol. 2014;29(12):911–27.PubMedCrossRef
8.
Boffetta P, Bobak M, Borsch-Supan A, Brenner H, Eriksson S, Grodstein F, et al. The consortium on health and ageing: network of cohorts in Europe and the United States (CHANCES) project-design, population and data harmonization of a large-scale, international study. Eur J Epidemiol. 2014;29(12):929–36.PubMedCrossRef
9.
Zeller T, Hughes M, Tuovinen T, Schillert A, Conrads-Frank A, den Ruijter H, et al. BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries. Eur J Epidemiol. 2014;29(10):777–90.PubMedCentralPubMedCrossRef
10.
Hofmann B. Diagnosing overdiagnosis: conceptual challenges and suggested solutions. Eur J Epidemiol. 2014;29(9):599–604.PubMedCrossRef
11.
Greiser KH, Linseisen J, Schmidt B, Wichmann HE. German Natl Cohort GNCC. The German National Cohort: aims, study design and organization. Eur J Epidemiol. 2014;29(5):371–82.CrossRef
12.
Karp I, Miettinen OS. On the essentials of etiological research for preventive medicine. Eur J Epidemiol. 2014;29(7):455–7.PubMedCrossRef
13.
Meulepas JM, Ronckers CM, Smets A, Nievelstein RAJ, Jahnen A, Lee C, et al. Leukemia and brain tumors among children after radiation exposure from CT scans: design and methodological opportunities of the Dutch Pediatric CT Study. Eur J Epidemiol. 2014;29(4):293–301.PubMedCrossRef
14.
Nyren O, Stenbeck M, Gronberg H. The European Parliament proposal for the new EU general data protection regulation may severely restrict European epidemiological research. Eur J Epidemiol. 2014;29(4):227–30.PubMedCentralPubMedCrossRef
15.
Raoult D, Henrissat B. Are stool samples suitable for studying the link between gut microbiota and obesity? Eur J Epidemiol. 2014;29(5):307–9.PubMedCrossRef
16.
Rosendaal FR. National registers and their use for medical research. Eur J Epidemiol. 2014;29(8):539–40.PubMedCrossRef
17.
Schmidt M, Pedersen L, Sorensen HT. The Danish civil registration system as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–9.PubMedCrossRef
18.
Thygesen LC, Ersboll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551–8.PubMedCrossRef
19.
Weiss NS. All-cause mortality as an outcome in epidemiologic studies: proceed with caution. Eur J Epidemiol. 2014;29(3):147–9.PubMedCrossRef
20.
Forsberg JS, Hansson MG, Evers K. International guidelines on biobank research leave researchers in ambiguity: Why is this so? Eur J Epidemiol. 2013;28(6):449–51.PubMedCrossRef
21.
Fu M, Martinez-Sanchez JM, Sureda X, Martinez C, Ballbe M, Baranda L, et al. Handwritten versus scanned signature on the invitation letter: Does it make any difference in participation in a population-based study? Eur J Epidemiol. 2013;28(11):931–4.PubMedCrossRef
22.
Hunink MGM. Meta-analysis of diagnostic performance studies. Eur J Epidemiol. 2013;28(9):711–2.CrossRef
23.
Jockel KH, Stang A. Cohort studies with low baseline response may not be generalisable to populations with different exposure distributions. Eur J Epidemiol. 2013;28(3):223–7.PubMedCrossRef
24.
Koller MT, van Delden C, Muller NJ, Baumann P, Lovis C, Marti HP, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol. 2013;28(4):347–55.PubMedCentralPubMedCrossRef
25.
de Mutsert R, den Heijer M, Rabelink TJ, Smit JWA, Romijn JA, Jukema JW, et al. The Netherlands epidemiology of obesity (NEO) study: study design and data collection. Eur J Epidemiol. 2013;28(6):513–23.PubMedCrossRef
26.
Parker LA, Saez NG, Porta M, Hernandez-Aguado I, Lumbreras B. The impact of including different study designs in meta-analyses of diagnostic accuracy studies. Eur J Epidemiol. 2013;28(9):713–20.PubMedCrossRef
27.
VanderWeele TJ. Reconsidering the denominator of the attributable proportion for interaction. Eur J Epidemiol. 2013;28(10):779–84.PubMedCrossRef
28.
Wallborn T, Grafe N, Quante M, Geserick M, Casprzig N, Ludwig J, et al. Never plan a population based cohort study on a rainy friday after a sunny thursday. Eur J Epidemiol. 2013;28(3):285–6.PubMedCrossRef
29.
Dhana K, Kavousi M, Ikram MA, Tiemeier H, Hofman A, Franco OH. Body shape index in comparison with other anthropometric measures in prediction of total and cause-specific mortality. J Epidemiol Community Health. 2015. doi: 10.​1136/​jech-2014-205257.
30.
Hagg S, Fall T, Ploner A, Magi R, Fischer K, Draisma HH, et al. Adiposity as a cause of cardiovascular disease: a Mendelian randomization study. Int J Epidemiol. 2015;44(2):578–86.PubMedCrossRef
31.
Fall T, Hagg S, Ploner A, Magi R, Fischer K, Draisma HH, et al. Age- and sex-specific causal effects of adiposity on cardiovascular risk factors. Diabetes. 2015;64(5):1841–52.PubMedCrossRef
32.
Kavousi M, Leening MJ, Nanchen D, Greenland P, Graham IM, Steyerberg EW, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014;311(14):1416–23.PubMedCrossRef
33.
van Dijk GM, Kavousi M, Troup J, Franco OH. Health issues for menopausal women: the top 11 conditions have common solutions. Maturitas. 2015;80(1):24–30.PubMedCrossRef
34.
Jaspers L, Daan NM, van Dijk GM, Gazibara T, Muka T, Wen KX, et al. Health in middle-aged and elderly women: a conceptual framework for healthy menopause. Maturitas. 2015;81(1):93–8.PubMedCrossRef
35.
Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, et al. Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ. 2014;349:g5992.PubMedCentralPubMedCrossRef
36.
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, et al. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure the Rotterdam Study. Eur Heart J. 2004;25(18):1614–9.PubMedCrossRef
37.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Herpen G, Stricker BH, et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam Study. Eur Heart J. 2006;27(8):949–53.PubMedCrossRef
38.
Krijthe BP, Kunst A, Benjamin EJ, Lip GY, Franco OH, Hofman A, et al. Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J. 2013;34(35):2746–51.PubMedCentralPubMedCrossRef
39.
Nanchen D, Leening MJ, Locatelli I, Cornuz J, Kors JA, Heeringa J, et al. Resting heart rate and the risk of heart failure in healthy adults: the Rotterdam Study. Circ Heart Fail. 2013;6(3):403–10.PubMedCrossRef
40.
van Vark LC, Kardys I, Bleumink GS, Knetsch AM, Deckers JW, Hofman A, et al. Lipoprotein-associated phospholipase A2 activity and risk of heart failure: the Rotterdam Study. Eur Heart J. 2006;27(19):2346–52.PubMedCrossRef
41.
Heeringa J, van der Kuip DA, Hofman A, Kors JA, van Rooij FJ, Lip GY, et al. Subclinical atherosclerosis and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2007;167(4):382–7.PubMedCrossRef
42.
Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam Study. Arch Intern Med. 2008;168(20):2219–24.PubMedCrossRef
43.
Krijthe BP, de Jong FH, Hofman A, Franco OH, Witteman JC, Stricker BH, et al. Dehydroepiandrosterone sulfate levels and risk of atrial fibrillation: the Rotterdam Study. Eur J Prev Cardiol. 2014;21(3):291–8.PubMedCrossRef
44.
Alonso A, Krijthe BP, Aspelund T, Stepas KA, Pencina MJ, Moser CB, et al. Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013;2(2):e000102.PubMedCentralPubMedCrossRef
45.
Vasan RS, Glazer NL, Felix JF, Lieb W, Wild PS, Felix SB, et al. Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data. JAMA. 2009;302(2):168–78.PubMedCentralPubMedCrossRef
46.
Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, et al. Genome-wide association study of PR interval. Nat Genet. 2010;42(2):153–9.PubMedCentralPubMedCrossRef
47.
den Hoed M, Eijgelsheim M, Esko T, Brundel BJ, Peal DS, Evans DM, et al. Identification of heart rate-associated loci and their effects on cardiac conduction and rhythm disorders. Nat Genet. 2013;45(6):621–31.CrossRef
48.
Benjamin EJ, Rice KM, Arking DE, Pfeufer A, van Noord C, Smith AV, et al. Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. Nat Genet. 2009;41(8):879–81.PubMedCentralPubMedCrossRef
49.
Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, et al. Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet. 2012;44(6):670–5.PubMedCentralPubMedCrossRef
50.
Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132(4):270–8.PubMedCrossRef
51.
Kavousi M, Elias-Smale S, Rutten JH, Leening MJ, Vliegenthart R, Verwoert GC, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438–44.PubMedCrossRef
52.
Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al. Amino-terminal pro-B-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: the Rotterdam Study. Hypertension. 2010;55(3):785–91.PubMedCrossRef
53.
Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam Study. Eur Heart J. 2006;27(11):1331–7.PubMedCrossRef
54.
Oei HH, van der Meer IM, Hofman A, Koudstaal PJ, Stijnen T, Breteler MM, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111(5):570–5.PubMedCrossRef
55.
van der Bom JG, de Knijff P, Haverkate F, Bots ML, Meijer P, de Jong PT, et al. Tissue plasminogen activator and risk of myocardial infarction. The Rotterdam Study. Circulation. 1997;95(12):2623–7.PubMedCrossRef
56.
Ligthart S, Sedaghat S, Ikram MA, Hofman A, Franco OH, Dehghan A. EN-RAGE: a novel inflammatory marker for incident coronary heart disease. Arterioscler Thromb Vasc Biol. 2014;34(12):2695–9.PubMedCrossRef
57.
Koller MT, Leening MJ, Wolbers M, Steyerberg EW, Hunink MG, Schoop R, et al. Development and validation of a coronary risk prediction model for older U.S. and European persons in the Cardiovascular Health study and the Rotterdam Study. Ann Intern Med. 2012;157(6):389–97.PubMedCentralPubMedCrossRef
58.
Dhana K, Ikram MA, Hofman A, Franco OH, Kavousi M. Anthropometric measures in cardiovascular disease prediction: comparison of laboratory-based versus non-laboratory-based model. Heart. 2015;101(5):377–83.PubMedCrossRef
59.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96(5):1432–7.PubMedCrossRef
60.
Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: the Rotterdam Study. Circulation. 2006;113(5):657–63.PubMedCrossRef
61.
Vliegenthart R, Oudkerk M, Hofman A, Oei HH, van Dijck W, van Rooij FJ, et al. Coronary calcification improves cardiovascular risk prediction in the elderly. Circulation. 2005;112(4):572–7.PubMedCrossRef
62.
van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109(9):1089–94.PubMedCrossRef
63.
Elias-Smale SE, Proenca RV, Koller MT, Kavousi M, van Rooij FJ, Hunink MG, et al. Coronary calcium score improves classification of coronary heart disease risk in the elderly: the Rotterdam Study. J Am Coll Cardiol. 2010;56(17):1407–14.PubMedCrossRef
64.
Kavousi M, Leening MJ, Witteman JC. Markers for prediction of cardiovascular disease risk. JAMA. 2012;308(24):2561 author reply -2.PubMedCrossRef
65.
Elias-Smale SE, Wieberdink RG, Odink AE, Hofman A, Hunink MG, Koudstaal PJ, et al. Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study. Eur Heart J. 2011;32(16):2050–8.PubMedCrossRef
66.
Leening MJ, Elias-Smale SE, Kavousi M, Felix JF, Deckers JW, Vliegenthart R, et al. Coronary calcification and the risk of heart failure in the elderly: the Rotterdam Study. JACC Cardiovasc Imaging. 2012;5(9):874–80.PubMedCrossRef
67.
Kardys I, Klaver CC, Despriet DD, Bergen AA, Uitterlinden AG, Hofman A, et al. A common polymorphism in the complement factor H gene is associated with increased risk of myocardial infarction: the Rotterdam Study. J Am Coll Cardiol. 2006;47(8):1568–75.PubMedCrossRef
68.
Psaty BM, Hofman A. Genome-wide association studies and large-scale collaborations in epidemiology. Eur J Epidemiol. 2010;25(8):525–9.PubMedCrossRef
69.
Psaty BM, O’Donnell CJ, Gudnason V, Lunetta KL, Folsom AR, Rotter JI, et al. Cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium: design of prospective meta-analyses of genome-wide association studies from 5 cohorts. Circ Cardiovasc Genet. 2009;2(1):73–80.PubMedCentralPubMedCrossRef
70.
Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F, et al. Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet. 2008;372(9654):1953–61.PubMedCentralPubMedCrossRef
71.
Yu B, Li AH, Muzny D, Veeraraghavan N, de Vries PS, Bis JC, et al. Association of rare loss-of-function alleles in HAL, serum histidine: levels and incident coronary heart disease. Circ Cardiovasc Genet. 2015;8(2):351–5.PubMedCrossRef
72.
Kottgen A, Glazer NL, Dehghan A, Hwang SJ, Katz R, Li M, et al. Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet. 2009;41(6):712–7.PubMedCentralPubMedCrossRef
73.
International Consortium for Blood Pressure Genome-Wide Association S, Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478(7367):103–9.CrossRef
74.
Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, Dehghan A, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41(6):677–87.PubMedCentralPubMedCrossRef
75.
Wain LV, Verwoert GC, O’Reilly PF, Shi G, Johnson T, Johnson AD, et al. Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet. 2011;43(10):1005–11.PubMedCentralPubMedCrossRef
76.
Ganesh SK, Zakai NA, van Rooij FJ, Soranzo N, Smith AV, Nalls MA, et al. Multiple loci influence erythrocyte phenotypes in the CHARGE consortium. Nat Genet. 2009;41(11):1191–8.PubMedCentralPubMedCrossRef
77.
Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, et al. Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels. Circulation. 2011;123(7):731–8.PubMedCentralPubMedCrossRef
78.
Smith JG, Platonov PG, Hedblad B, Engstrom G, Melander O. Atrial fibrillation in the Malmo diet and cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol. 2010;25(2):95–102.PubMedCrossRef
79.
Huffman JE, de Vries PS, Morrison AC, Sabater-Lleal M, Kacprowski T, Auer PL, et al. Rare and low-frequency variants and their association with plasma levels of fibrinogen, FVII, FVIII, and vWF. Blood. 2015;126(11):e19–29.
80.
de Vries PS, Boender J, Sonneveld MA, Rivadeneira F, Ikram MA, Rottensteiner H, et al. Genetic variants in the ADAMTS13 and SUPT3H genes are associated with ADAMTS13 activity. Blood. 2015;125(25):3949–55.PubMedCrossRef
81.
Bis JC, Kavousi M, Franceschini N, Isaacs A, Abecasis GR, Schminke U, et al. Meta-analysis of genome-wide association studies from the CHARGE consortium identifies common variants associated with carotid intima media thickness and plaque. Nat Genet. 2011;43(10):940–7.PubMedCentralPubMedCrossRef
82.
Murabito JM, White CC, Kavousi M, Sun YV, Feitosa MF, Nambi V, et al. Association between chromosome 9p21 variants and the ankle-brachial index identified by a meta-analysis of 21 genome-wide association studies. Circ Cardiovasc Genet. 2012;5(1):100–12.PubMedCentralPubMedCrossRef
83.
O’Donnell CJ, Kavousi M, Smith AV, Kardia SL, Feitosa MF, Hwang SJ, et al. Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction. Circulation. 2011;124(25):2855–64.PubMedCentralPubMedCrossRef
84.
Consortium CAD, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45(1):25–33.
85.
Schunkert H, Konig IR, Kathiresan S, Reilly MP, Assimes TL, Holm H, et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet. 2011;43(4):333–8.PubMedCentralPubMedCrossRef
86.
de Vries PS, Kavousi M, Ligthart S, Uitterlinden AG, Hofman A, Franco OH, et al. Incremental predictive value of 152 single nucleotide polymorphisms in the 10-year risk prediction of incident coronary heart disease: the Rotterdam Study. Int J Epidemiol. 2015;44(2):682–8.PubMedCrossRef
87.
Steenaard RV, Ligthart S, Stolk L, Peters MJ, van Meurs JB, Uitterlinden AG, et al. Tobacco smoking is associated with methylation of genes related to coronary artery disease. Clin Epigenet. 2015;14:7.
88.
Ghanbari M, de Vries PS, de Looper H, Peters MJ, Schurmann C, Yaghootkar H, et al. A genetic variant in the seed region of miR-4513 shows pleiotropic effects on lipid and glucose homeostasis, blood pressure, and coronary artery disease. Hum Mutat. 2014;35(12):1524–31.PubMedCrossRef
89.
Ghanbari M, Sedaghat S, de Looper HW, Hofman A, Erkeland SJ, Franco OH, et al. The association of common polymorphisms in miR-196a2 with waist to hip ratio and miR-1908 with serum lipid and glucose. Obesity (Silver Spring). 2015;23(2):495–503.CrossRef
90.
Ghanbari M, Franco OH, de Looper HW, Hofman A, Erkeland SJ, Dehghan A. Genetic Variations in MicroRNA-binding SITES affect MicroRNA-mediated regulation of several genes associated with cardio-metabolic phenotypes. Circ Cardiovasc Genet. 2015;8(3):473–86.PubMedCrossRef
91.
Heine-Broring RC, Brouwer IA, Proenca RV, van Rooij FJ, Hofman A, Oudkerk M, et al. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr. 2010;91(5):1317–23.PubMedCrossRef
92.
van Woudenbergh GJ, Kuijsten A, Tigcheler B, Sijbrands EJ, van Rooij FJ, Hofman A, et al. Meat consumption and its association with C-reactive protein and incident type 2 diabetes: the Rotterdam Study. Diabetes Care. 2012;35(7):1499–505.PubMedCentralPubMedCrossRef
93.
Muka T, Kiefte-de Jong JC, Hofman A, Dehghan A, Rivadeneira F, Franco OH. Polyunsaturated fatty acids and serum C-reactive protein: the Rotterdam Study. Am J Epidemiol. 2015;181(11):846–56.PubMedCrossRef
94.
Altorf-van der Kuil W, Engberink MF, De Neve M, van Rooij FJ, Hofman A, van’t Veer P, et al. Dietary amino acids and the risk of hypertension in a Dutch older population: the Rotterdam Study. Am J Clin Nutr. 2013;97(2):403–10.PubMedCrossRef
95.
Altorf-van der Kuil W, Engberink MF, van Rooij FJ, Hofman A, van’t Veer P, Witteman JC, et al. Dietary protein and risk of hypertension in a Dutch older population: the Rotterdam Study. J Hypertens. 2010;28(12):2394–400.PubMed
96.
Engberink MF, Bakker SJ, Brink EJ, van Baak MA, van Rooij FJ, Hofman A, et al. Dietary acid load and risk of hypertension: the Rotterdam Study. Am J Clin Nutr. 2012;95(6):1438–44.PubMedCrossRef
97.
Vitezova A, Zillikens MC, van Herpt TT, Sijbrands EJ, Hofman A, Uitterlinden AG, et al. Vitamin D status and metabolic syndrome in the elderly: the Rotterdam Study. Eur J Endocrinol. 2015;172(3):327–35.PubMedCrossRef
98.
Vitezova A, Cartolano NS, Heeringa J, Zillikens MC, Hofman A, Franco OH, et al. Vitamin D and the risk of atrial fibrillation—the Rotterdam Study. PLoS ONE. 2015;10(5):e0125161.PubMedCentralPubMedCrossRef
99.
Mirza SS, Tiemeier H, de Bruijn RF, Hofman A, Franco OH, Kiefte-de Jong J, et al. Coffee consumption and incident dementia. Eur J Epidemiol. 2014;29(10):735–41.PubMedCrossRef
100.
Praagman J, Franco OH, Ikram MA, Soedamah-Muthu SS, Engberink MF, van Rooij FJ, et al. Dairy products and the risk of stroke and coronary heart disease: the Rotterdam Study. Eur J Nutr. 2015;54(6):981–90.
101.
Bos D, Shahzad R, van Walsum T, van Vliet LJ, Franco OH, Hofman A, et al. Epicardial fat volume is related to atherosclerotic calcification in multiple vessel beds. Eur Heart J Cardiovasc Imaging. 2015.
102.
Jankovic N, Geelen A, Streppel MT, de Groot LC, Orfanos P, van den Hooven EH, et al. Adherence to a healthy diet according to the World Health Organization guidelines and all-cause mortality in elderly adults from Europe and the United States. Am J Epidemiol. 2014;180(10):978–88.PubMedPubMedCentralCrossRef
103.
Zillikens MC, van Meurs JB, Rivadeneira F, Hofman A, Oostra BA, Sijbrands EJ, et al. Interactions between dietary vitamin E intake and SIRT1 genetic variation influence body mass index. Am J Clin Nutr. 2010;91(5):1387–93.PubMedCrossRef
104.
Hruby A, Ngwa JS, Renstrom F, Wojczynski MK, Ganna A, Hallmans G, et al. Higher magnesium intake is associated with lower fasting glucose and insulin, with no evidence of interaction with select genetic loci, in a meta-analysis of 15 CHARGE Consortium Studies. J Nutr. 2013;143(3):345–53.PubMedCentralPubMedCrossRef
105.
Kanoni S, Nettleton JA, Hivert MF, Ye Z, van Rooij FJ, Shungin D, et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort meta-analysis. Diabetes. 2011;60(9):2407–16.PubMedCentralPubMedCrossRef
106.
Nettleton JA, Hivert MF, Lemaitre RN, McKeown NM, Mozaffarian D, Tanaka T, et al. Meta-analysis investigating associations between healthy diet and fasting glucose and insulin levels and modification by loci associated with glucose homeostasis in data from 15 cohorts. Am J Epidemiol. 2013;177(2):103–15.PubMedCentralPubMedCrossRef
107.
Dashti HS, Follis JL, Smith CE, Tanaka T, Garaulet M, Gottlieb DJ, et al. Gene-environment interactions of circadian-related genes for cardiometabolic traits. Diabetes Care. 2015;38(8):1456–66.
108.
Freak-Poli R, Mirza SS, Franco OH, Ikram MA, Hofman A, Tiemeier H. Positive affect is not associated with incidence of cardiovascular disease: a population-based study of older persons. Prev Med. 2015;74:14–20.PubMedCrossRef
109.
Zuurbier LA, Luik AI, Leening MJ, Hofman A, Freak-Poli R, Franco OH, et al. Associations of heart failure with sleep quality: the Rotterdam Study. J Clin Sleep Med. 2015;11(2):117–21.PubMedCentralPubMed
110.
Leening MJ, Kavousi M, Heeringa J, van Rooij FJ, Verkroost-van Heemst J, Deckers JW, et al. Methods of data collection and definitions of cardiac outcomes in the Rotterdam Study. Eur J Epidemiol. 2012;27(3):173–85.PubMedCentralPubMedCrossRef
111.
Smith NL, Chen MH, Dehghan A, Strachan DP, Basu S, Soranzo N, et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for heart and aging research in genome epidemiology) consortium. Circulation. 2010;121(12):1382–92.PubMedCentralPubMedCrossRef
112.
Dehghan A, Kardys I, de Maat MP, Uitterlinden AG, Sijbrands EJ, Bootsma AH, et al. Genetic variation, C-reactive protein levels, and incidence of diabetes. Diabetes. 2007;56(3):872–8.PubMedCrossRef
113.
Straus SM, Kors JA, De Bruin ML, van der Hooft CS, Hofman A, Heeringa J, et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol. 2006;47(2):362–7.PubMedCrossRef
114.
Kardys I, Deckers JW, Stricker BH, Vletter WB, Hofman A, Witteman J. Distribution of echocardiographic parameters and their associations with cardiovascular risk factors in the Rotterdam Study. Eur J Epidemiol. 2010;25(7):481–90.PubMedCentralPubMedCrossRef
115.
Klipstein-Grobusch K, den Breeijen JH, Goldbohm RA, Geleijnse JM, Hofman A, Grobbee DE, et al. Dietary assessment in the elderly: validation of a semiquantitative food frequency questionnaire. Eur J Clin Nutr. 1998;52(8):588–96.PubMedCrossRef
116.
Feunekes GI, Van Staveren WA, De Vries JH, Burema J, Hautvast JG. Relative and biomarker-based validity of a food-frequency questionnaire estimating intake of fats and cholesterol. Am J Clin Nutr. 1993;58(4):489–96.PubMed
117.
Goldbohm RA, van den Brandt PA, Brants HA, van’t Veer P, Al M, Sturmans F, et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr. 1994;48(4):253–65.PubMed
118.
Goldbohm RA, van’t Veer P, van den Brandt PA, van’t Hof MA, van’t Hof HA, Brants HA, Sturmans F, et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr. 1995;49(6):420–9.PubMed
119.
Siebelink E, Geelen A, de Vries JH. Self-reported energy intake by FFQ compared with actual energy intake to maintain body weight in 516 adults. Br J Nutr. 2011;106(2):274–81.PubMedCrossRef
120.
Caspersen CJ, Bloemberg BP, Saris WH, Merritt RK, Kromhout D. The prevalence of selected physical activities and their relation with coronary heart disease risk factors in elderly men: the Zutphen Study, 1985. Am J Epidemiol. 1991;133(11):1078–92.PubMed
121.
Stel VS, Smit JH, Pluijm SM, Visser M, Deeg DJ, Lips P. Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol. 2004;57(3):252–8.PubMedCrossRef
122.
Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A Physical Activity Questionnaire for the elderly. Med Sci Sports Exerc. 1991;23(8):974–9.PubMedCrossRef
123.
Arabshahi S, Busingye D, Subasinghe AK, Evans RG, Riddell MA, Thrift AG. Adiposity has a greater impact on hypertension in lean than not-lean populations: a systematic review and meta-analysis. Eur J Epidemiol. 2014;29(5):311–24.PubMedCrossRef
124.
Blix K, Braekkan SK, le Cessie S, Skjeldestad FE, Cannegieter SC, Hansen JB. The increased risk of venous thromboembolism by advancing age cannot be attributed to the higher incidence of cancer in the elderly: the Tromso study. Eur J Epidemiol. 2014;29(4):277–84.PubMedCrossRef
125.
Eveborn GW, Schirmer H, Lunde P, Heggelund G, Hansen JB, Rasmussen K. Assessment of risk factors for developing incident aortic stenosis: the Tromso study. Eur J Epidemiol. 2014;29(8):567–75.PubMedCrossRef
126.
Greenwood DC, Thatcher NJ, Ye J, Garrard L, Keogh G, King LG, et al. Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. Eur J Epidemiol. 2014;29(10):725–34.PubMedCrossRef
127.
Gunnell AS, Knuiman MW, Divitini ML, Cormie P. Leisure time physical activity and long-term cardiovascular and cancer outcomes: the Busselton Health study. Eur J Epidemiol. 2014;29(11):851–7.PubMedCrossRef
128.
Hillesund ER, Overby NC, Engel SM, Klungsoyr K, Harmon QE, Haugen M, et al. Associations of adherence to the New Nordic Diet with risk of preeclampsia and preterm delivery in the Norwegian Mother and Child Cohort Study (MoBa). Eur J Epidemiol. 2014;29(10):753–65.PubMedCrossRef
129.
Holtermann A, Mork PJ, Nilsen TIL. Hours lying down per day and mortality from all-causes and cardiovascular disease: the HUNT Study, Norway. Eur J Epidemiol. 2014;29(8):559–65.PubMedCrossRef
130.
Horvei LD, Braekkan SK, Mathiesen EB, Njolstad I, Wilsgaard T, Hansen JB. Obesity measures and risk of venous thromboembolism and myocardial infarction. Eur J Epidemiol. 2014;29(11):821–30.PubMedCrossRef
131.
Icks A, Claessen H, Kirchberger I, Heier M, Peters A, Trentinaglia I, et al. Mortality after first myocardial infarction in diabetic and non-diabetic people between 1985 and 2009. The MONICA/KORA registry. Eur J Epidemiol. 2014;29(12):899–909.PubMedCrossRef
132.
Ilar A, Lewne M, Plato N, Hallqvist J, Alderling M, Bigert C, et al. Myocardial infarction and occupational exposure to motor exhaust: a population-based case-control study in Sweden. Eur J Epidemiol. 2014;29(7):517–25.PubMedCrossRef
133.
James JE. Personalised medicine, disease prevention, and the inverse care law: More harm than benefit? Eur J Epidemiol. 2014;29(6):383–90.PubMedCrossRef
134.
Jdanov DA, Deev AD, Jasilionis D, Shalnova SA, Shkolnikova MA, Shkolnikov VM. Recalibration of the SCORE risk chart for the Russian population. Eur J Epidemiol. 2014;29(9):621–8.PubMedPubMedCentralCrossRef
135.
Knuiman M, Briffa T, Divitini M, Chew D, Eikelboom J, McQuillan B, et al. A cohort study examination of established and emerging risk factors for atrial fibrillation: the Busselton Health study. Eur J Epidemiol. 2014;29(3):181–90.PubMedCrossRef
136.
Leenders M, Boshuizen HC, Ferrari P, Siersema PD, Overvad K, Tjonneland A, et al. Fruit and vegetable intake and cause-specific mortality in the EPIC study. Eur J Epidemiol. 2014;29(9):639–52.PubMedCrossRef
137.
Martinsson A, Andersson C, Andell P, Koul S, Engstrom G, Smith JG. Anemia in the general population: prevalence, clinical correlates and prognostic impact. Eur J Epidemiol. 2014;29(7):489–98.PubMedCrossRef
138.
Niedziela J, Hudzik B, Niedziela N, Gasior M, Gierlotka M, Wasilewski J, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801–12.PubMedCentralPubMedCrossRef
139.
Nordahl H, Rod NH, Frederiksen BL, Andersen I, Lange T, Diderichsen F, et al. Education and risk of coronary heart disease: assessment of mediation by behavioral risk factors using the additive hazards model. Eur J Epidemiol. 2013;28(2):149–57.PubMedCrossRef
140.
O’Doherty MG, Jorgensen T, Borglykke A, Brenner H, Schottker B, Wilsgaard T, et al. Repeated measures of body mass index and C-reactive protein in relation to all-cause mortality and cardiovascular disease: results from the consortium on health and ageing network of cohorts in Europe and the United States (CHANCES). Eur J Epidemiol. 2014;29(12):887–97.PubMedCrossRef
141.
Song X, Pukkala E, Dyba T, Tuomilehto J, Moltchanov V, Mannisto S, et al. Body mass index and cancer incidence: the FINRISK study. Eur J Epidemiol. 2014;29(7):477–87.PubMedCrossRef
142.
Turney BW, Appleby PN, Reynard JM, Noble JG, Key TJ, Allen NE. Diet and risk of kidney stones in the Oxford cohort of the European prospective investigation into cancer and nutrition (EPIC). Eur J Epidemiol. 2014;29(5):363–9.PubMedCrossRef
143.
Ueda P, Cnattingius S, Stephansson O, Ingelsson E, Ludvigsson JF, Bonamy AKE. Cerebrovascular and ischemic heart disease in young adults born preterm: a population-based Swedish cohort study. Eur J Epidemiol. 2014;29(4):253–60.PubMedCrossRef
144.
Wald NJ, Morris JK. Quantifying the health benefits of chronic disease prevention: a fresh approach using cardiovascular disease as an example. Eur J Epidemiol. 2014;29(9):605–12.PubMedCentralPubMedCrossRef
145.
Ahmadi-Abhari S, Luben RN, Wareham NJ, Khaw KT. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study. Eur J Epidemiol. 2013;28(7):541–50.PubMedCrossRef
146.
Etemadi A, Abnet CC, Kamangar F, Islami F, Khademi H, Pourshams A, et al. Impact of body size and physical activity during adolescence and adult life on overall and cause-specific mortality in a large cohort study from Iran. Eur J Epidemiol. 2014;29(2):95–109.PubMedCrossRef
147.
Gellert C, Schottker B, Muller H, Holleczek B, Brenner H. Impact of smoking and quitting on cardiovascular outcomes and risk advancement periods among older adults. Eur J Epidemiol. 2013;28(8):649–58.PubMedCrossRef
148.
149.
His M, Zelek L, Deschasaux M, Pouchieu C, Kesse-Guyot E, Hercberg S, et al. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk. Eur J Epidemiol. 2014;29(2):119–32.PubMedCrossRef
150.
Iversen B, Jacobsen BK, Lochen ML. Active and passive smoking and the risk of myocardial infarction in 24,968 men and women during 11 year of follow-up: the Tromso study. Eur J Epidemiol. 2013;28(8):659–67.PubMedCentralPubMedCrossRef
151.
Jha P. The 21st century benefits of smoking cessation in Europe. Eur J Epidemiol. 2013;28(8):617–9.PubMedCrossRef
152.
Julin B, Wolk A, Thomas LD, Akesson A. Exposure to cadmium from food and risk of cardiovascular disease in men: a population-based prospective cohort study. Eur J Epidemiol. 2013;28(10):837–40.PubMedCrossRef
153.
Kelly-Irving M, Lepage B, Dedieu D, Bartley M, Blane D, Grosclaude P, et al. Adverse childhood experiences and premature all-cause mortality. Eur J Epidemiol. 2013;28(9):721–34.PubMedCentralPubMedCrossRef
154.
Kulik MC, Hoffmann R, Judge K, Looman C, Menvielle G, Kulhanova I, et al. Smoking and the potential for reduction of inequalities in mortality in Europe. Eur J Epidemiol. 2013;28(12):959–71.PubMedCrossRef
155.
Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: Causal association or epiphenomenon? Eur J Epidemiol. 2014;29(1):1–14.PubMedCrossRef
156.
Li KR, Monni S, Husing A, Wendt A, Kneisel J, Gross ML, et al. Primary preventive potential of major lifestyle risk factors for acute myocardial infarction in men: an analysis of the EPIC-Heidelberg cohort. Eur J Epidemiol. 2014;29(1):27–34.PubMedCrossRef
157.
Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, et al. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol. 2013;28(7):527–39.PubMedCrossRef
158.
159.
Novak M, Toren K, Lappas G, Kok WG, Jern C, Wilhelmsen L, et al. Occupational status and incidences of ischemic and hemorrhagic stroke in Swedish men: a population-based 35-year prospective follow-up study. Eur J Epidemiol. 2013;28(8):697–704.PubMedCrossRef
160.
Schmidt M, Botker HE, Pedersen L, Sorensen HT. Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study. Eur J Epidemiol. 2014;29(2):111–8.PubMedCrossRef
161.
Ueda P, Bonamy AKE, Granath F, Cnattingius S. Month of birth and cause-specific mortality between 50 and 80 years: a population-based longitudinal cohort study in Sweden. Eur J Epidemiol. 2014;29(2):89–94.PubMedCrossRef
162.
Bamia C, Lagiou P, Buckland G, Grioni S, Agnoli C, Taylor AJ, et al. Mediterranean diet and colorectal cancer risk: results from a European cohort. Eur J Epidemiol. 2013;28(4):317–28.PubMedCrossRef
163.
Behrens G, Fischer B, Kohler S, Park Y, Hollenbeck AR, Leitzmann MF. Healthy lifestyle behaviors and decreased risk of mortality in a large prospective study of U.S. women and men. Eur J Epidemiol. 2013;28(5):361–72.PubMedCrossRef
164.
Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28(1):1–19.PubMedCrossRef
165.
Clays E, De Bacquer D, Janssens H, De Clercq B, Casini A, Braeckman L, et al. The association between leisure time physical activity and coronary heart disease among men with different physical work demands: a prospective cohort study. Eur J Epidemiol. 2013;28(3):241–7.PubMedCrossRef
166.
Faeh D, Rohrmann S, Braun J. Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts. Eur J Epidemiol. 2013;28(7):551–5.PubMedCrossRef
167.
Hjellvik V, Selmer R, Gjessing HK, Tverdal A, Vollset SE. Body mass index, smoking, and risk of death between 40 and 70 years of age in a Norwegian cohort of 32,727 women and 33,475 men. Eur J Epidemiol. 2013;28(1):35–43.PubMedCrossRef
168.
Jorde R, Schirmer H, Njolstad I, Lochen ML, Mathiesen EB, Kamycheva E, et al. Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromso study. Eur J Epidemiol. 2013;28(7):569–78.PubMedCrossRef
169.
Karppi J, Kurl S, Makikallio TH, Ronkainen K, Laukkanen JA. Low levels of plasma carotenoids are associated with an increased risk of atrial fibrillation. Eur J Epidemiol. 2013;28(1):45–53.PubMedCrossRef
170.
Kunutsor SK, Apekey TA, Steur M. Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–21.PubMedCrossRef
171.
Leening MJG, Cook NR. Net reclassification improvement: a link between statistics and clinical practice. Eur J Epidemiol. 2013;28(1):21–3.PubMedCrossRef
172.
Leon DA, Shkolnikov VM, Borinskaya S, Casas JP, Evans A, Gil A, et al. Hazardous alcohol consumption is associated with increased levels of B-type natriuretic peptide: evidence from two population-based studies. Eur J Epidemiol. 2013;28(5):393–404.PubMedCentralPubMedCrossRef
173.
Mackenbach JP. Convergence and divergence of life expectancy in Europe: a centennial view. Eur J Epidemiol. 2013;28(3):229–40.PubMedCrossRef
174.
McKee M, Legido-Quigley H, Piot P. Trends in life expectancy in Europe: one big explanation or many small ones? Eur J Epidemiol. 2013;28(3):203–4.PubMedCrossRef
175.
Miettola S, Hartikainen AL, Vaarasmaki M, Bloigu A, Ruokonen A, Jarvelin MR, et al. Offspring’s blood pressure and metabolic phenotype after exposure to gestational hypertension in utero. Eur J Epidemiol. 2013;28(1):87–98.PubMedCrossRef
176.
Mishra GD, Chiesa F, Goodman A, De Stavola B, Koupil I. Socio-economic position over the life course and all-cause, and circulatory diseases mortality at age 50–87 years: results from a Swedish birth cohort. Eur J Epidemiol. 2013;28(2):139–47.PubMedCrossRef
177.
Muhlenbruch K, Heraclides A, Steyerberg EW, Joost HG, Boeing H, Schulze MB. Assessing improvement in disease prediction using net reclassification improvement: impact of risk cut-offs and number of risk categories. Eur J Epidemiol. 2013;28(1):25–33.PubMedCrossRef
178.
Panczak R, Galobardes B, Spoerri A, Zwahlen M, Egger M. High life in the sky? Mortality by floor of residence in Switzerland. Eur J Epidemiol. 2013;28(6):453–62.PubMedCentralPubMedCrossRef
179.
Ribeiro A, Fatima de Pina M. Could moderate earthquakes also trigger cardiac events? Eur J Epidemiol. 2013;28(2):199–202.PubMedCrossRef
180.
Takahara M, Katakami N, Kaneto H, Shimomura I. Risk categorization for calculating net reclassification improvement. Eur J Epidemiol. 2013;28(7):607–9.PubMedCentralPubMedCrossRef
181.
Threapleton DE, Greenwood DC, Burley VJ, Aldwairji M, Cade JE. Dietary fibre and cardiovascular disease mortality in the UK Women’s Cohort study. Eur J Epidemiol. 2013;28(4):335–46.PubMedCrossRef
182.
Wu YL, Li SR, Zhang DF. Circulating 25-hydroxyvitamin D levels and hypertension risk. Eur J Epidemiol. 2013;28(7):611–6.PubMedCrossRef
183.
Flohil SC, van der Leest RJ, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol. 2013;133(8):1971–8.PubMedCrossRef
184.
Verkouteren JA, Pardo LM, Uitterlinden AG, Hofman A, Nijsten T. Common variants affecting susceptibility to develop multiple basal cell carcinomas. J Invest Dermatol. 2015;135(8):2135–8.
185.
Jacobs LC, Hamer MA, Gunn DA, Deelen J, Lall JS, van Heemst D, et al. A genome-wide association study identifies the skin color genes IRF4, MC1R, ASIP, and BNC2 influencing facial pigmented spots. J Invest Dermatol. 2015;135(7):1735–42.PubMedCrossRef
186.
Jacobs LC, Wollstein A, Lao O, Hofman A, Klaver CC, Uitterlinden AG, et al. Comprehensive candidate gene study highlights UGT1A and BNC2 as new genes determining continuous skin color variation in Europeans. Hum Genet. 2013;132(2):147–58.PubMedCrossRef
187.
Liu F, Visser M, Duffy DL, Hysi PG, Jacobs LC, Lao O, et al. Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up. Hum Genet. 2015;134(8):823–35.
188.
Dowlatshahi EA, Kavousi M, Nijsten T, Ikram MA, Hofman A, Franco OH, et al. Psoriasis is not associated with atherosclerosis and incident cardiovascular events: the Rotterdam Study. J Invest Dermatol. 2013;133(10):2347–54.PubMedCrossRef
189.
van der Voort EA, Koehler EM, Dowlatshahi EA, Hofman A, Stricker BH, Janssen HL, et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J Am Acad Dermatol. 2014;70(3):517–24.PubMedCrossRef
190.
van der Voort EA, Koehler EM, Nijsten T, Stricker BH, Hofman A, Janssen HL, et al. Increased prevalence of advanced liver fibrosis in patients with psoriasis: a cross-sectional analysis from the Rotterdam Study. Acta Derm Venereol. 2015. doi:10.​2340/​00015555-2161.
191.
Oei L, Rivadeneira F, Ly F, Breda SJ, Zillikens MC, Hofman A, et al. Review of radiological scoring methods of osteoporotic vertebral fractures for clinical and research settings. Eur Radiol. 2013;23(2):476–86.PubMedCrossRef
192.
Makurthou AA, Oei L, Saddy SE, Breda SJ, Castano-Betancourt MC, Hofman A, et al. Scheuermann’s disease: evaluation of radiological criteria and population prevalence. Spine (Phila Pa 1976). 2013.
193.
Oei L, Zillikens MC, Dehghan A, Buitendijk GH, Castano-Betancourt MC, Estrada K, et al. High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study. Diabetes Care. 2013;36(6):1619–28.PubMedCentralPubMedCrossRef
194.
Castano-Betancourt MC, Rivadeneira F, Bierma-Zeinstra S, Kerkhof HJ, Hofman A, Uitterlinden AG, et al. Bone parameters across different types of hip osteoarthritis and their relationship to osteoporotic fracture risk. Arthritis Rheum. 2013;65(3):693–700.PubMedCrossRef
195.
Castano-Betancourt MC, Van Meurs JB, Bierma-Zeinstra S, Rivadeneira F, Hofman A, Weinans H, et al. The contribution of hip geometry to the prediction of hip osteoarthritis. Osteoarthritis Cartilage. 2013;21(10):1530–6.PubMedCrossRef
196.
Kerkhof HJ, Bierma-Zeinstra SM, Arden NK, Metrustry S, Castano-Betancourt M, Hart DJ, et al. Prediction model for knee osteoarthritis incidence, including clinical, genetic and biochemical risk factors. Ann Rheum Dis. 2014;73(12):2116–21.PubMedCrossRef
197.
Valdes AM, Meulenbelt I, Chassaing E, Arden NK, Bierma-Zeinstra S, Hart D, et al. Large scale meta-analysis of urinary C-terminal telopeptide, serum cartilage oligomeric protein and matrix metalloprotease degraded type II collagen and their role in prevalence, incidence and progression of osteoarthritis. Osteoarthritis Cartilage. 2014;22(5):683–9.PubMedCrossRef
198.
Hoeven TA, Kavousi M, Clockaerts S, Kerkhof HJ, van Meurs JB, Franco O, et al. Association of atherosclerosis with presence and progression of osteoarthritis: the Rotterdam Study. Ann Rheum Dis. 2013;72(5):646–51.PubMedCrossRef
199.
Hoeven TA, Leening MJ, Bindels PJ, Castano-Betancourt M, van Meurs JB, Franco OH, et al. Disability and not osteoarthritis predicts cardiovascular disease: a prospective population-based cohort study. Ann Rheum Dis. 2015;74(4):752–6.PubMedCrossRef
200.
Schiphof D, Kerkhof HJ, Damen J, de Klerk BM, Hofman A, Koes BW, et al. Factors for pain in patients with different grades of knee osteoarthritis. Arthritis Care Res (Hoboken). 2013;65(5):695–702.CrossRef
201.
de Kruijf M, Kerkhof HJ, Peters MJ, Bierma-Zeinstra S, Hofman A, Uitterlinden AG, et al. Finger length pattern as a biomarker for osteoarthritis and chronic joint pain: a population-based study and meta-analysis after systematic review. Arthritis Care Res (Hoboken). 2014;66(9):1337–43.CrossRef
202.
Chaker L, Buitendijk GH, Dehghan A, Medici M, Hofman A, Vingerling JR, et al. Thyroid function and age-related macular degeneration: a prospective population-based cohort study–the Rotterdam Study. BMC Med. 2015;13:94.PubMedCentralPubMedCrossRef
203.
Medici M, Direk N, Visser WE, Korevaar TI, Hofman A, Visser TJ, et al. Thyroid function within the normal range and the risk of depression: a population-based cohort study. J Clin Endocrinol Metab. 2014;99(4):1213–9.PubMedCrossRef
204.
van der Loos MJ, Haring R, Rietveld CA, Baumeister SE, Groenen PJ, Hofman A, et al. Serum testosterone levels in males are not associated with entrepreneurial behavior in two independent observational studies. Physiol Behav. 2013;2(119):110–4.CrossRef
205.
Blum MR, Bauer DC, Collet TH, Fink HA, Cappola AR, da Costa BR, et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055–65.PubMedCrossRef
206.
Chaker L, Baumgartner C, den Elzen WP, Ikram MA, Blum MR, Collet TH, et al. Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis. J Clin Endocrinol Metab. 2015;100(6):2181–91.PubMedCrossRef
207.
Asvold BO, Vatten LJ, Bjoro T, Bauer DC, Bremner A, Cappola AR, et al. Thyroid function within the normal range and risk of coronary heart disease: an individual participant data analysis of 14 cohorts. JAMA Intern Med. 2015;175(6):1037–47.PubMedCrossRef
208.
Estrada K, Styrkarsdottir U, Evangelou E, Hsu YH, Duncan EL, Ntzani EE, et al. Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet. 2012;44(5):491–501.PubMedCentralPubMedCrossRef
209.
Zeggini E, Panoutsopoulou K, Southam L, Rayner NW, et al. Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study. Lancet. 2012;380(9844):815–823.
210.
Castano Betancourt MC, Cailotto F, Kerkhof HJ, Cornelis FM, Doherty SA, Hart DJ, et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc Natl Acad Sci USA. 2012;109(21):8218–23.PubMedCentralPubMedCrossRef
211.
Peters MJ, Broer L, Willemen HL, Eiriksdottir G, Hocking LJ, Holliday KL, et al. Genome-wide association study meta-analysis of chronic widespread pain: evidence for involvement of the 5p15.2 region. Ann Rheum Dis. 2013;72(3):427–36.PubMedCentralPubMedCrossRef
212.
Rodriguez-Fontenla C, Calaza M, Evangelou E, Valdes AM, Arden N, Blanco FJ, et al. Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies. Arthritis Rheumatol. 2014;66(4):940–9.PubMedPubMedCentralCrossRef
213.
Ramos YF, Metrustry S, Arden N, Bay-Jensen AC, Beekman M, de Craen AJ, et al. Meta-analysis identifies loci affecting levels of the potential osteoarthritis biomarkers sCOMP and uCTX-II with genome wide significance. J Med Genet. 2014;51(9):596–604.PubMedCrossRef
214.
Styrkarsdottir U, Thorleifsson G, Helgadottir HT, Bomer N, Metrustry S, Bierma-Zeinstra S, et al. Severe osteoarthritis of the hand associates with common variants within the ALDH1A2 gene and with rare variants at 1p31. Nat Genet. 2014;46(5):498–502.PubMedCrossRef
215.
Stolk L, Perry JR, Chasman DI, He C, Mangino M, Sulem P, et al. Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet. 2012;44(3):260–8.PubMedCentralPubMedCrossRef
216.
Porcu E, Medici M, Pistis G, Volpato CB, Wilson SG, Cappola AR, et al. A meta-analysis of thyroid-related traits reveals novel loci and gender-specific differences in the regulation of thyroid function. PLoS Genet. 2013;9(2):e1003266.PubMedCentralPubMedCrossRef
217.
Medici M, Porcu E, Pistis G, Teumer A, Brown SJ, Jensen RA, et al. Identification of novel genetic loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet. 2014;10(2):e1004123.PubMedCentralPubMedCrossRef
218.
Schultheiss UT, Teumer A, Medici M, Li Y, Daya N, Chaker L, et al. A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations. J Clin Endocrinol Metab. 2015;100(5):E799–807.PubMedCrossRef
219.
Mayerle J, den Hoed CM, Schurmann C, Stolk L, Homuth G, Peters MJ, et al. Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA. 2013;309(18):1912–20.PubMedCrossRef
220.
Aune D, Norat T, Romundstad P, Vatten LJ. Whole grain and refined grain consumption and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Eur J Epidemiol. 2013;28(11):845–58.PubMedCrossRef
221.
Bloch F. Not only the traumatic falls in elderly subjects requires awareness but all the falls even those hitherto regarded as unimportant. Eur J Epidemiol. 2014;29(9):663–4.PubMedCrossRef
222.
Buijsse B, Boeing H, Hirche F, Weikert C, Schulze MB, Gottschald M, et al. Plasma 25-hydroxyvitamin D and its genetic determinants in relation to incident type 2 diabetes: a prospective case-cohort study. Eur J Epidemiol. 2013;28(9):743–52.PubMedCrossRef
223.
Chaker L, Baumgartner C, Ikram MA, Dehghan A, Medici M, Visser WE, et al. Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis. Eur J Epidemiol. 2014;29(11):791–800.PubMedCrossRef
224.
Dai XY, Yuan J, Yao P, Yang BY, Gui LX, Zhang XM, et al. Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population. Eur J Epidemiol. 2013;28(8):669–76.PubMedCrossRef
225.
Fagherazzi G, Vilier A, Lajous M, Boutron-Ruault MC, Balkau B, Clavel-Chapelon F, et al. Wine consumption throughout life is inversely associated with type 2 diabetes risk, but only in overweight individuals: results from a large female French cohort study. Eur J Epidemiol. 2014;29(11):831–9.PubMedCrossRef
226.
Frisch M, Nielsen NM, Pedersen BV. Same-sex marriage, autoimmune thyroid gland dysfunction and other autoimmune diseases in Denmark 1989–2008. Eur J Epidemiol. 2014;29(1):63–71.PubMedCrossRef
227.
Janghorbani M, Momeni F, Mansourian M. Systematic review and metaanalysis of air pollution exposure and risk of diabetes. Eur J Epidemiol. 2014;29(4):231–42.PubMedCrossRef
228.
Lagiou P, Samoli E, Hsieh CC, Lagiou A, Xu B, Yu GP, et al. Maternal and cord blood hormones in relation to birth size. Eur J Epidemiol. 2014;29(5):343–51.PubMedCrossRef
229.
Lahousse L, Maes B, Ziere G, Loth DW, Verlinden VJA, Zillikens MC, et al. Adverse outcomes of frailty in the elderly: the Rotterdam Study. Eur J Epidemiol. 2014;29(6):419–27.PubMedCrossRef
230.
Min JY, Min KB. Serum C-peptide levels as an independent predictor of diabetes mellitus mortality in non-diabetic individuals. Eur J Epidemiol. 2013;28(9):771–4.PubMedCrossRef
231.
Naver KV, Secher NJ, Ovesen PG, Gorst-Rasmussen A, Lundbye-Christensen S, Nilas L. Offspring preterm birth and birth size are related to long-term risk of maternal diabetes. Eur J Epidemiol. 2013;28(5):427–32.PubMedCrossRef
232.
Ostroumova E, Gudzenko N, Brenner A, Gorokh Y, Hatch M, Prysyazhnyuk A, et al. Thyroid cancer incidence in Chornobyl liquidators in Ukraine: SIR analysis, 1986–2010. Eur J Epidemiol. 2014;29(5):337–42.PubMedCrossRef
233.
Sabanayagam C, Wong TY, Xiao J, Shankar A. Serum cystatin C and prediabetes in non-obese US adults. Eur J Epidemiol. 2013;28(4):311–6.PubMedCrossRef
234.
Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N, et al. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol. 2013;28(2):169–80.PubMedCentralPubMedCrossRef
235.
Saum KU, Dieffenbach AK, Muller H, Holleczek B, Hauer K, Brenner H. Frailty prevalence and 10-year survival in community-dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol. 2014;29(3):171–9.PubMedCrossRef
236.
Schmid D, Behrens G, Jochem C, Keimling M, Leitzmann M. Physical activity, diabetes, and risk of thyroid cancer: a systematic review and meta-analysis. Eur J Epidemiol. 2013;28(12):945–58.PubMedCrossRef
237.
Schottker B, Herder C, Rothenbacher D, Perna L, Muller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large population-based cohort of older adults. Eur J Epidemiol. 2013;28(3):267–75.PubMedCrossRef
238.
Schottker B, Saum KU, Perna L, Ordonez-Mena JM, Holleczek B, Brenner H. Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health? Eur J Epidemiol. 2014;29(3):199–210.PubMedCrossRef
239.
Schram MT, Sep SJS, van der Kallen CJ, Dagnelie PC, Koster A, Schaper N, et al. The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol. 2014;29(6):439–51.PubMedCrossRef
240.
Vinceti M, Malagoli C, Rothman KJ, Rodolfi R, Astolfi G, Calzolari E, et al. Risk of birth defects associated with maternal pregestational diabetes. Eur J Epidemiol. 2014;29(6):411–8.PubMedCrossRef
241.
Weyer V, Blettner M, Cholmakow-Bodechtel C, Heudorf U. Chemical accident at Hoechst AG Frankfurt/Main, Germany, 1993: a 15 year follow-up analysis of mortality. Eur J Epidemiol. 2014;29(1):73–6.PubMedCrossRef
242.
Yao BD, Fang H, Xu WH, Yan YJ, Xu HL, Liu YN, et al. Dietary fiber intake and risk of type 2 diabetes: a dose-response analysis of prospective studies. Eur J Epidemiol. 2014;29(2):79–88.PubMedCrossRef
243.
Hamaguchi M, Kojima T, Itoh Y, Harano Y, Fujii K, Nakajima T, et al. The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation. Am J Gastroenterol. 2007;102(12):2708–15.PubMedCrossRef
244.
Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol. 2003;29(12):1705–13.PubMedCrossRef
245.
Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2007;5(10):1214–20.PubMedCrossRef
246.
Koehler EM, Schouten JN, Hansen BE, van Rooij FJ, Hofman A, Stricker BH, et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam Study. J Hepatol. 2012;57(6):1305–11.PubMedCrossRef
247.
de Keyser CE, Koehler EM, Schouten JN, Visser LE, Hofman A, Janssen HL, et al. Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Dig Liver Dis. 2014;46(8):720–5.PubMedCrossRef
248.
Koehler EM, Schouten JN, Hansen BE, Hofman A, Stricker BH, Janssen HL. External validation of the fatty liver index for identifying nonalcoholic fatty liver disease in a population-based study. Clin Gastroenterol Hepatol. 2013;11(9):1201–4.PubMedCrossRef
249.
Koehler EM, Sanna D, Hansen BE, van Rooij FJ, Heeringa J, Hofman A, et al. Serum liver enzymes are associated with all-cause mortality in an elderly population. Liver Int. 2014;34(2):296–304.PubMedCrossRef
250.
Plompen EP, Hansen BE, Schouten JN, Darwish Murad S, Loth DW, Brouwer WP, et al. Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study. Gut. 2015;64(4):692–4.PubMedCrossRef
251.
Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbee DE, et al. Prevalence of Alzheimer’s disease and vascular dementia: association with education. The Rotterdam Study. BMJ. 1995;310(6985):970–3.PubMedCentralPubMedCrossRef
252.
de Rijk MC, Breteler MM, Graveland GA, Ott A, Grobbee DE, van der Meche FG, et al. Prevalence of Parkinson’s disease in the elderly: the Rotterdam Study. Neurology. 1995;45(12):2143–6.PubMedCrossRef
253.
Ruitenberg A, Ott A, van Swieten JC, Hofman A, Breteler MM. Incidence of dementia: Does gender make a difference? Neurobiol Aging. 2001;22(4):575–80.PubMedCrossRef
254.
Hollander M, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Breteler MM. Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study. J Neurol Neurosurg Psychiatry. 2003;74(3):317–21.PubMedCentralPubMedCrossRef
255.
de Lau LM, Giesbergen PC, de Rijk MC, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study. Neurology. 2004;63(7):1240–4.PubMedCrossRef
256.
257.
Schrijvers EM, Verhaaren BF, Koudstaal PJ, Hofman A, Ikram MA, Breteler MM. Is dementia incidence declining? Trends in dementia incidence since 1990 in the Rotterdam Study. Neurology. 2012;78(19):1456–63.PubMedCrossRef
258.
Wieberdink RG, Ikram MA, Hofman A, Koudstaal PJ, Breteler MM. Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008. Eur J Epidemiol. 2012;27(4):287–95.PubMedCentralPubMedCrossRef
259.
Breteler MM, Claus JJ, Grobbee DE, Hofman A. Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam Study. BMJ. 1994;308(6944):1604–8.PubMedCentralPubMedCrossRef
260.
261.
Hofman A, Ott A, Breteler MM, Bots ML, Slooter AJ, van Harskamp F, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam Study. Lancet. 1997;349(9046):151–4.PubMedCrossRef
262.
Ott A, Slooter AJ, Hofman A, van Harskamp F, Witteman JC, Van Broeckhoven C, et al. Smoking and risk of dementia and Alzheimer’s disease in a population-based cohort study: the Rotterdam Study. Lancet. 1998;351(9119):1840–3.PubMedCrossRef
263.
Ruitenberg A, van Swieten JC, Witteman JC, Mehta KM, van Duijn CM, Hofman A, et al. Alcohol consumption and risk of dementia: the Rotterdam Study. Lancet. 2002;359(9303):281–6.PubMedCrossRef
264.
de Bruijn RF, Schrijvers EM, de Groot KA, Witteman JC, Hofman A, Franco OH, et al. The association between physical activity and dementia in an elderly population: the Rotterdam Study. Eur J Epidemiol. 2013;28(3):277–83.PubMedCrossRef
265.
in t’ Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer’s disease. N Engl J Med. 2001;345(21):1515–21.PubMedCrossRef
266.
Euser SM, van Bemmel T, Schram MT, Gussekloo J, Hofman A, Westendorp RG, et al. The effect of age on the association between blood pressure and cognitive function later in life. J Am Geriatr Soc. 2009;57(7):1232–7.PubMedCrossRef
267.
Euser SM, Sattar N, Witteman JC, Bollen EL, Sijbrands EJ, Hofman A, et al. A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes. 2010;59(7):1601–7.PubMedCentralPubMedCrossRef
268.
Hollander M, Bots ML, Del Sol AI, Koudstaal PJ, Witteman JC, Grobbee DE, et al. Carotid plaques increase the risk of stroke and subtypes of cerebral infarction in asymptomatic elderly: the Rotterdam Study. Circulation. 2002;105(24):2872–7.PubMedCrossRef
269.
Wieberdink RG, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM, Ikram MA. Insulin resistance and the risk of stroke and stroke subtypes in the nondiabetic elderly. Am J Epidemiol. 2012;176(8):699–707.PubMedCrossRef
270.
Wieberdink RG, Poels MM, Vernooij MW, Koudstaal PJ, Hofman A, van der Lugt A, et al. Serum lipid levels and the risk of intracerebral hemorrhage: the Rotterdam Study. Arterioscler Thromb Vasc Biol. 2011;31(12):2982–9.PubMedCrossRef
271.
Bos MJ, Schipper CM, Koudstaal PJ, Witteman JC, Hofman A, Breteler MM. High serum C-reactive protein level is not an independent predictor for stroke: the Rotterdam Study. Circulation. 2006;114(15):1591–8.PubMedCrossRef
272.
Ferket BS, van Kempen BJ, Wieberdink RG, Steyerberg EW, Koudstaal PJ, Hofman A, et al. Separate prediction of intracerebral hemorrhage and ischemic stroke. Neurology. 2014;82(20):1804–12.PubMedCentralPubMedCrossRef
273.
Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–22.PubMedCrossRef
274.
Vernooij MW, Ikram MA, Tanghe HL, Vincent AJ, Hofman A, Krestin GP, et al. Incidental findings on brain MRI in the general population. N Engl J Med. 2007;357(18):1821–8.PubMedCrossRef
275.
de Bruijn RF, Portegies ML, Leening MJ, Bos MJ, Hofman A, van der Lugt A, et al. Subclinical cardiac dysfunction increases the risk of stroke and dementia: the Rotterdam Study. Neurology. 2015;84(8):833–40.PubMedCrossRef
276.
Bos D, Vernooij MW, de Bruijn RF, Koudstaal PJ, Hofman A, Franco OH, et al. Atherosclerotic calcification is related to a higher risk of dementia and cognitive decline. Alzheimers Dement. 2015;11(6):639–647 e1.PubMedCrossRef
277.
Sajjad A, Mirza SS, Portegies ML, Bos MJ, Hofman A, Koudstaal PJ, et al. Subjective memory complaints and the risk of stroke. Stroke. 2015;46(1):170–5.PubMedCrossRef
278.
Desikan RS, Schork AJ, Wang Y, Thompson WK, Dehghan A, Ridker PM, et al. Polygenic overlap between C-reactive protein, plasma lipids, and Alzheimer disease. Circulation. 2015;131(23):2061–9.PubMedCrossRef
279.
Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med. 2009;360(17):1718–28.PubMedCentralPubMedCrossRef
280.
Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet. 2013;45(12):1452–8.PubMedCentralPubMedCrossRef
281.
Schrijvers EM, Schurmann B, Koudstaal PJ, van den Bussche H, Van Duijn CM, Hentschel F, et al. Genome-wide association study of vascular dementia. Stroke. 2012;43(2):315–9.PubMedCrossRef
282.
Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M, et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA. 2010;303(18):1832–40.PubMedCentralPubMedCrossRef
283.
Verhaaren BF, Vernooij MW, Dehghan A, Vrooman HA, de Boer R, Hofman A, et al. The relation of uric acid to brain atrophy and cognition: the Rotterdam Scan Study. Neuroepidemiology. 2013;41(1):29–34.PubMedCrossRef
284.
Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology. 1994;44(7):1246–52.PubMedCrossRef
285.
Ikram MA, van der Lugt A, Niessen WJ, Krestin GP, Koudstaal PJ, Hofman A, et al. The Rotterdam Scan Study: design and update up to 2012. Eur J Epidemiol. 2011;26(10):811–24.PubMedCentralPubMedCrossRef
286.
Ikram MA, van Oijen M, de Jong FJ, Kors JA, Koudstaal PJ, Hofman A, et al. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke. 2008;39(5):1421–6.PubMedCrossRef
287.
Ikram MA, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, Breteler MM. Kidney function is related to cerebral small vessel disease. Stroke. 2008;39(1):55–61.PubMedCrossRef
288.
Ikram MA, Vrooman HA, Vernooij MW, van der Lijn F, Hofman A, van der Lugt A, et al. Brain tissue volumes in the general elderly population. The Rotterdam Scan Study. Neurobiol Aging. 2008;29(6):882–90.PubMedCrossRef
289.
Ikram MK, de Jong FJ, Vernooij MW, Hofman A, Niessen WJ, van der Lugt A, et al. Retinal vascular calibers associate differentially with cerebral gray matter and white matter atrophy. Alzheimer Dis Assoc Disord. 2013;27(4):351–5.PubMedCrossRef
290.
Poels MM, Zaccai K, Verwoert GC, Vernooij MW, Hofman A, van der Lugt A, et al. Arterial stiffness and cerebral small vessel disease: the Rotterdam Scan Study. Stroke. 2012;43(10):2637–42.PubMedCrossRef
291.
Poels MM, Steyerberg EW, Wieberdink RG, Hofman A, Koudstaal PJ, Ikram MA, et al. Assessment of cerebral small vessel disease predicts individual stroke risk. J Neurol Neurosurg Psychiatry. 2012;83(12):1174–9.PubMedCrossRef
292.
Saavedra Perez HC, Direk N, Hofman A, Vernooij MW, Tiemeier H, Ikram MA. Silent brain infarcts: A cause of depression in the elderly? Psychiatry Res. 2013;211(2):180–2.PubMedCrossRef
293.
Ikram MA, Vernooij MW, Vrooman HA, Hofman A, Breteler MM. Brain tissue volumes and small vessel disease in relation to the risk of mortality. Neurobiol Aging. 2009;30(3):450–6.PubMedCrossRef
294.
Ikram MA, Vrooman HA, Vernooij MW, den Heijer T, Hofman A, Niessen WJ, et al. Brain tissue volumes in relation to cognitive function and risk of dementia. Neurobiol Aging. 2010;31(3):378–86.PubMedCrossRef
295.
Verlinden VJ, van der Geest JN, de Groot M, Hofman A, Niessen WJ, van der Lugt A, et al. Structural and microstructural brain changes predict impairment in daily functioning. Am J Med. 2014;127(11):1089–1096 e2.PubMedCrossRef
296.
Bis JC, DeCarli C, Smith AV, van der Lijn F, Crivello F, Fornage M, et al. Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet. 2012;44(5):545–51.PubMedCentralPubMedCrossRef
297.
Debette S, Bis JC, Fornage M, Schmidt H, Ikram MA, Sigurdsson S, et al. Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE consortium. Stroke. 2010;41(2):210–7.PubMedCentralPubMedCrossRef
298.
Fornage M, Debette S, Bis JC, Schmidt H, Ikram MA, Dufouil C, et al. Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol. 2011;69(6):928–39.PubMedCentralPubMedCrossRef
299.
300.
Ikram MA, Fornage M, Smith AV, Seshadri S, Schmidt R, Debette S, et al. Common variants at 6q22 and 17q21 are associated with intracranial volume. Nat Genet. 2012;44(5):539–44.PubMedCentralPubMedCrossRef
301.
Stein JL, Medland SE, Vasquez AA, Hibar DP, Senstad RE, Winkler AM, et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet. 2012;44(5):552–61.PubMedCentralPubMedCrossRef
302.
Verhaaren BF, de Boer R, Vernooij MW, Rivadeneira F, Uitterlinden AG, Hofman A, et al. Replication study of chr17q25 with cerebral white matter lesion volume. Stroke. 2011;42(11):3297–9.PubMedCrossRef
303.
Verlinden VJ, van der Geest JN, Hoogendam YY, Hofman A, Breteler MM, Ikram MA. Gait patterns in a community-dwelling population aged 50 years and older. Gait Posture. 2013;37(4):500–5.PubMedCrossRef
304.
Loehrer E, Vernooij MW, van der Lugt A, Hofman A, Ikram MA. Migraine and cerebral blood flow in the general population. Cephalalgia. 2015;35(2):190–8.PubMedCrossRef
305.
Bos MJ, van Rijn MJ, Witteman JC, Hofman A, Koudstaal PJ, Breteler MM. Incidence and prognosis of transient neurological attacks. JAMA. 2007;298(24):2877–85.PubMedCrossRef
306.
Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.PubMedCrossRef
307.
Killgore WD, Glahn DC, Casasanto DJ. Development and validation of the design organization test (DOT): a rapid screening instrument for assessing visuospatial ability. J Clin Exp Neuropsychol. 2005;27(4):449–59.PubMedCrossRef
308.
Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci. 1997;145(2):205–11.PubMedCrossRef
309.
de Bruijn R, Schrijvers EMC, de Groot KA, Witteman JCM, Hofman A, Franco OH, et al. The association between physical activity and dementia in an elderly population: the Rotterdam Study (vol 28, pg 277, 2013). Eur J Epidemiol. 2013;28(5):447–8.CrossRef
310.
Dufouil C, Pereira E, Chene G, Glymour MM, Alperovitch A, Saubusse E, et al. Older age at retirement is associated with decreased risk of dementia. Eur J Epidemiol. 2014;29(5):353–61.PubMedCrossRef
311.
Feldman AL, Wirdefeldt K, Johansson ALV, Gatz M, Pedersen NL. Evidence for modest familial co-aggregation between dementia and parkinsonism. Eur J Epidemiol. 2014;29(1):49–56.PubMedCrossRef
312.
Grant WB. The role of milk protein in increasing risk of Parkinson’s disease. Eur J Epidemiol. 2013;28(4):357.PubMedCrossRef
313.
Hamidou B, Couratier P, Besancon C, Nicol M, Preux PM, Marin B. Epidemiological evidence that physical activity is not a risk factor for ALS. Eur J Epidemiol. 2014;29(7):459–75.PubMedCrossRef
314.
Hoogendam YY, Hofman A, van der Geest JN, van der Lugt A, Ikram MA. Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol. 2014;29(2):133–40.PubMedCrossRef
315.
Jacqmin-Gadda H, Alperovitch A, Montlahuc C, Commenges D, Leffondre K, Dufouil C, et al. 20-year prevalence projections for dementia and impact of preventive policy about risk factors. Eur J Epidemiol. 2013;28(6):493–502.PubMedCrossRef
316.
Jiang WJ, Ju CX, Jiang H, Zhang DF. Dairy foods intake and risk of Parkinson’s disease: a dose-response meta-analysis of prospective cohort studies. Eur J Epidemiol. 2014;29(9):613–9.PubMedCrossRef
317.
Kyrozis A, Ghika A, Stathopoulos P, Vassilopoulos D, Trichopoulos D, Trichopoulou A. Dietary and lifestyle variables in relation to incidence of Parkinson’s disease in Greece. Eur J Epidemiol. 2013;28(1):67–77.PubMedCrossRef
318.
Lai SW, Liao KF, Lin CL, Sung FC. Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan. Eur J Epidemiol. 2014;29(1):57–62.PubMedCrossRef
319.
Marioni RE, Proust-Lima C, Amieva H, Brayne C, Matthews FE, Dartigues JF, et al. Cognitive lifestyle jointly predicts longitudinal cognitive decline and mortality risk. Eur J Epidemiol. 2014;29(3):211–9.PubMedCentralPubMedCrossRef
320.
Mensikova K, Kanovsky P, Kaiserova M, Mikulicova L, Vastik M, Hlustik P, et al. Prevalence of neurodegenerative parkinsonism in an isolated population in south-eastern Moravia, Czech Republic. Eur J Epidemiol. 2013;28(10):833–6.PubMedCrossRef
321.
Mons U, Schottker B, Muller H, Kliegel M, Brenner H. History of lifetime smoking, smoking cessation and cognitive function in the elderly population. Eur J Epidemiol. 2013;28(10):823–31.PubMedCrossRef
322.
Nevalainen O, Raitanen J, Ansakorpi H, Artama M, Isojarvi J, Auvinen A. Long-term mortality risk by cause of death in newly diagnosed patients with epilepsy in Finland: a nationwide register-based study. Eur J Epidemiol. 2013;28(12):981–90.PubMedCrossRef
323.
Palm F, Dos Santos M, Urbanek C, Greulich M, Zimmer K, Safer A, et al. Stroke seasonality associations with subtype, etiology and laboratory results in the Ludwigshafen Stroke study (LuSSt). Eur J Epidemiol. 2013;28(5):373–81.PubMedCrossRef
324.
Pekmezovic T, Jovic J, Svetel M, Kostic VS. Prevalence of restless legs syndrome among adult population in a Serbian district: a community-based study. Eur J Epidemiol. 2013;28(11):927–30.PubMedCrossRef
325.
Pellegrino P, Carnovale C, Perrone V, Antoniazzi S, Pozzi M, Clementi E, et al. No evidence of a link between multiple sclerosis and the vaccine against the human papillomavirus. Eur J Epidemiol. 2013;28(8):705–7.PubMedCrossRef
326.
Schernhammer E, Qiu JH, Wermuth L, Lassen CF, Friis S, Ritz B. Gout and the risk of Parkinson’s disease in Denmark. Eur J Epidemiol. 2013;28(4):359–60.PubMedCentralPubMedCrossRef
327.
Skoog I. Is it dangerous or beneficial to drink coffee? Reflections on a meta-analysis on risk at birth and a population study on risk in late life. Eur J Epidemiol. 2014;29(10):665–6.PubMedCrossRef
328.
Virta JJ, Heikkila K, Perola M, Koskenvuo M, Raiha I, Rinne JO, et al. Midlife cardiovascular risk factors and late cognitive impairment. Eur J Epidemiol. 2013;28(5):405–16.PubMedCrossRef
329.
Zhang ZZ, Xu GL, Liu DZ, Zhu WS, Fan XY, Liu XF. Dietary fiber consumption and risk of stroke. Eur J Epidemiol. 2013;28(2):119–30.PubMedCrossRef
330.
Klein R, Myers CE, Buitendijk GH, Rochtchina E, Gao X, de Jong PT, et al. Lipids, lipid genes, and incident age-related macular degeneration: the three continent age-related macular degeneration consortium. Am J Ophthalmol. 2014;158(3):513–524 e3.PubMedCentralPubMedCrossRef
331.
Wang JJ, Buitendijk GH, Rochtchina E, Lee KE, Klein BE, van Duijn CM, et al. Genetic susceptibility, dietary antioxidants, and long-term incidence of age-related macular degeneration in two populations. Ophthalmology. 2014;121(3):667–75.PubMedCrossRef
332.
Buitendijk GH, Amin N, Hofman A, van Duijn CM, Vingerling JR, Klaver CC. Direct-to-consumer personal genome testing for age-related macular degeneration. Invest Ophthalmol Vis Sci. 2014;55(10):6167–74.PubMedCrossRef
333.
Williams KM, Verhoeven VJ, Cumberland P, Bertelsen G, Wolfram C, Buitendijk GH, et al. Prevalence of refractive error in Europe: the European eye epidemiology (E(3)) consortium. Eur J Epidemiol. 2015;30(4):305–15.PubMedCentralPubMedCrossRef
334.
Williams KM, Bertelsen G, Cumberland P, Wolfram C, Verhoeven VJ, Anastasopoulos E, et al. Increasing prevalence of myopia in Europe and the impact of education. Ophthalmology. 2015;122(7):1489–97.PubMedCentralPubMedCrossRef
335.
Verhoeven VJ, Wong KT, Buitendijk GH, Hofman A, Vingerling JR, Klaver CC. Visual consequences of refractive errors in the general population. Ophthalmology. 2015;122(1):101–9.PubMedCrossRef
336.
Cheng CY, Schache M, Ikram MK, Young TL, Guggenheim JA, Vitart V, et al. Nine loci for ocular axial length identified through genome-wide association studies, including shared loci with refractive error. Am J Hum Genet. 2013;93(2):264–77.PubMedCentralPubMedCrossRef
337.
Simpson CL, Wojciechowski R, Oexle K, Murgia F, Portas L, Li X, et al. Genome-wide meta-analysis of myopia and hyperopia provides evidence for replication of 11 loci. PLoS ONE. 2014;9(9):e107110.PubMedCentralPubMedCrossRef
338.
Li Q, Wojciechowski R, Simpson CL, Hysi PG, Verhoeven VJ, Ikram MK, et al. Genome-wide association study for refractive astigmatism reveals genetic co-determination with spherical equivalent refractive error: the CREAM consortium. Hum Genet. 2015;134(2):131–46.PubMedCentralPubMedCrossRef
339.
Hysi PG, Cheng CY, Springelkamp H, Macgregor S, Bailey JN, Wojciechowski R, et al. Genome-wide analysis of multi-ancestry cohorts identifies new loci influencing intraocular pressure and susceptibility to glaucoma. Nat Genet. 2014;46(10):1126–30.PubMedCentralPubMedCrossRef
340.
Springelkamp H, Iglesias AI, Cuellar-Partida G, Amin N, Burdon KP, van Leeuwen EM, et al. ARHGEF12 influences the risk of glaucoma by increasing intraocular pressure. Hum Mol Genet. 2015;24(9):2689–99.PubMedCrossRef
341.
Springelkamp H, Hohn R, Mishra A, Hysi PG, Khor CC, Loomis SJ, et al. Meta-analysis of genome-wide association studies identifies novel loci that influence cupping and the glaucomatous process. Nat Commun. 2014;5:4883.PubMedCentralPubMedCrossRef
342.
Springelkamp H, Mishra A, Hysi PG, Gharahkhani P, Hohn R, Khor CC, et al. Meta-analysis of genome-wide association studies identifies novel loci associated with optic disc morphology. Genet Epidemiol. 2015;39(3):207–16.PubMedCrossRef
343.
Iglesias AI, Springelkamp H, van der Linde H, Severijnen LA, Amin N, Oostra B, et al. Exome sequencing and functional analyses suggest that SIX6 is a gene involved in an altered proliferation-differentiation balance early in life and optic nerve degeneration at old age. Hum Mol Genet. 2014;23(5):1320–32.PubMedCrossRef
344.
Springelkamp H, Lee K, Wolfs RC, Buitendijk GH, Ramdas WD, Hofman A, et al. Population-based evaluation of retinal nerve fiber layer, retinal ganglion cell layer, and inner plexiform layer as a diagnostic tool for glaucoma. Invest Ophthalmol Vis Sci. 2014;55(12):8428–38.PubMedCentralPubMedCrossRef
345.
He R, Shen J, Zhao J, Zeng H, Li LX, Zhao JG, et al. High cystatin C levels predict severe retinopathy in type 2 diabetes patients. Eur J Epidemiol. 2013;28(9):775–8.PubMedCrossRef
346.
La Torre G, Pacella E, Saulle R, Giraldi G, Pacella F, Lenzi T, et al. The synergistic effect of exposure to alcohol, tobacco smoke and other risk factors for age-related macular degeneration. Eur J Epidemiol. 2013;28(5):445–6.PubMedCrossRef
347.
Lai SW, Lin CL, Liao KF. Cataract may be a non-memory feature of Alzheimer’s disease in older people. Eur J Epidemiol. 2014;29(6):405–9.PubMedCrossRef
348.
Verhoeven VJM, Buitendijk GHS, Rivadeneira F, Uitterlinden AG, Vingerling JR, Hofman A, et al. Education influences the role of genetics in myopia. Eur J Epidemiol. 2013;28(12):973–80.PubMedCentralPubMedCrossRef
349.
Wang YX, Xu L, Jonas JB. The effect of the Chinese cultural revolution and great leap forward on the prevalence of myopia. Eur J Epidemiol. 2013;28(12):1001–4.PubMedCrossRef
350.
Tiemeier H, van Dijck W, Hofman A, Witteman JC, Stijnen T, Breteler MM. Relationship between atherosclerosis and late-life depression: the Rotterdam Study. Arch Gen Psychiatry. 2004;61(4):369–76.PubMedCrossRef
351.
Hek K, Demirkan A, Lahti J, Terracciano A, Teumer A, Cornelis MC, et al. A genome-wide association study of depressive symptoms. Biol Psychiatry. 2013;73(7):667–78.PubMedCrossRef
352.
Gottlieb DJ, Hek K, Chen TH, Watson NF, Eiriksdottir G, Byrne EM, et al. Novel loci associated with usual sleep duration: the CHARGE consortium genome-wide association study. Mol Psychiatry. 2014. doi:10.​1038/​mp.​2014.​133.
353.
Bolton JL, Hayward C, Direk N, Lewis JG, Hammond GL, Hill LA, et al. Genome wide association identifies common variants at the SERPINA6/SERPINA1 locus influencing plasma cortisol and corticosteroid binding globulin. PLoS Genet. 2014;10(7):e1004474.PubMedCentralPubMedCrossRef
354.
Ganna A, Rivadeneira F, Hofman A, Uitterlinden AG, Magnusson PK, Pedersen NL, et al. Genetic determinants of mortality. Can findings from genome-wide association studies explain variation in human mortality? Hum Genet. 2013;132(5):553–61.PubMedCrossRef
355.
Krijthe BP, Walter S, Newson RS, Hofman A, Hunink MG, Tiemeier H. Is positive affect associated with survival? A population-based study of elderly persons. Am J Epidemiol. 2011;173(11):1298–307.PubMedCrossRef
356.
Luijendijk HJ, van den Berg JF, Dekker MJ, van Tuijl HR, Otte W, Smit F, et al. Incidence and recurrence of late-life depression. Arch Gen Psychiatry. 2008;65(12):1394–401.PubMedCrossRef
357.
Hek K, Direk N, Newson RS, Hofman A, Hoogendijk WJ, Mulder CL, et al. Anxiety disorders and salivary cortisol levels in older adults: a population-based study. Psychoneuroendocrinology. 2013;38(2):300–5.PubMedCrossRef
358.
Van Den Berg JF, Van Rooij FJ, Vos H, Tulen JH, Hofman A, Miedema HM, et al. Disagreement between subjective and actigraphic measures of sleep duration in a population-based study of elderly persons. J Sleep Res. 2008;17(3):295–302.CrossRef
359.
Luik AI, Zuurbier LA, Whitmore H, Hofman A, Tiemeier H. REM sleep and depressive symptoms in a population-based study of middle-aged and elderly persons. J Sleep Res. 2015;24(3):305–8.PubMedCrossRef
360.
Zuurbier LA, Luik AI, Hofman A, Franco OH, Van Someren EJ, Tiemeier H. Fragmentation and stability of circadian activity rhythms predict mortality: the Rotterdam Study. Am J Epidemiol. 2015;181(1):54–63.PubMedCrossRef
361.
Newson RS, Hek K, Luijendijk HJ, Hofman A, Witteman JC, Tiemeier H. Atherosclerosis and incident depression in late life. Arch Gen Psychiatry. 2010;67(11):1144–51.PubMedCrossRef
362.
Direk N, Koudstaal PJ, Hofman A, Ikram MA, Hoogendijk WJ, Tiemeier H. Cerebral hemodynamics and incident depression: the Rotterdam Study. Biol Psychiatry. 2012;72(4):318–23.PubMedCrossRef
363.
van den Berg JF, Miedema HM, Tulen JH, Hofman A, Neven AK, Tiemeier H. Sex differences in subjective and actigraphic sleep measures: a population-based study of elderly persons. Sleep. 2009;32(10):1367–75.PubMedCentralPubMed
364.
Luik AI, Noteboom J, Zuurbier LA, Whitmore H, Hofman A, Tiemeier H. Sleep apnea severity and depressive symptoms in a population-based study. Sleep Health. 2015;1:128–32.CrossRef
365.
Hek K, Tiemeier H, Newson RS, Luijendijk HJ, Hofman A, Mulder CL. Anxiety disorders and comorbid depression in community dwelling older adults. Int J Methods Psychiatr Res. 2011;20(3):157–68.PubMedCrossRef
366.
Newson RS, Boelen PA, Hek K, Hofman A, Tiemeier H. The prevalence and characteristics of complicated grief in older adults. J Affect Disord. 2011;132(1–2):231–8.PubMedCrossRef
367.
Saavedra Perez HC, Ikram MA, Direk N, Prigerson HG, Freak-Poli R, Verhaaren BF, et al. Cognition, structural brain changes and complicated grief. A population-based study. Psychol Med. 2015;45(7):1389–99.PubMedCrossRef
368.
Rietveld CA, Cesarini D, Benjamin DJ, Koellinger PD, De Neve JE, Tiemeier H, et al. Molecular genetics and subjective well-being. Proc Natl Acad Sci USA. 2013;110(24):9692–7.PubMedCentralPubMedCrossRef
369.
Velders FP, Kuningas M, Kumari M, Dekker MJ, Uitterlinden AG, Kirschbaum C, et al. Genetics of cortisol secretion and depressive symptoms: a candidate gene and genome wide association approach. Psychoneuroendocrinology. 2011;36(7):1053–61.PubMedCentralPubMedCrossRef
370.
Walter S, Mackenbach J, Voko Z, Lhachimi S, Ikram MA, Uitterlinden AG, et al. Genetic, physiological, and lifestyle predictors of mortality in the general population. Am J Public Health. 2012;102(4):e3–10.PubMedCentralPubMedCrossRef
371.
Anic GM, Madden MH, Sincich K, Thompson RC, Nabors LB, Olson JJ, et al. Early life exposures and the risk of adult glioma. Eur J Epidemiol. 2013;28(9):753–8.PubMedCentralPubMedCrossRef
372.
Binachon B, Dossus L, Danjou AMN, Clavel-Chapelon F, Fervers B. Life in urban areas and breast cancer risk in the French E3N cohort. Eur J Epidemiol. 2014;29(10):743–51.PubMedCrossRef
373.
Eliasen M, Becker U, Gronbaek M, Juel K, Tolstrup JS. Alcohol-attributable and alcohol-preventable mortality in Denmark: an analysis of which intake levels contribute most to alcohol’s harmful and beneficial effects. Eur J Epidemiol. 2014;29(1):15–26.PubMedCrossRef
374.
Hwang IC, Shin D. Urinary sodium excretion is associated with short sleep duration. Eur J Epidemiol. 2014;29(12):937–40.PubMedCrossRef
375.
Kershaw KN, Droomers M, Robinson WR, Carnethon MR, Daviglus ML, Verschuren WMM. Quantifying the contributions of behavioral and biological risk factors to socioeconomic disparities in coronary heart disease incidence: the MORGEN study. Eur J Epidemiol. 2013;28(10):807–14.PubMedCrossRef
376.
Koppes LLJ, Geuskens GA, Pronk A, Vermeulen RCH, de Vroome EMM. Night work and breast cancer risk in a general population prospective cohort study in the Netherlands. Eur J Epidemiol. 2014;29(8):577–84.PubMedCrossRef
377.
Leinonen T, Lahelma E, Martikainen P. Trajectories of antidepressant medication before and after retirement: the contribution of socio-demographic factors. Eur J Epidemiol. 2013;28(5):417–26.PubMedCrossRef
378.
379.
Luque-Fernandez MA, Franco M, Gelaye B, Schomaker M, Garitano IG, D’Este C, et al. Unemployment and stillbirth risk among foreign-born and Spanish pregnant women in Spain, 2007–2010: a multilevel analysis study. Eur J Epidemiol. 2013;28(12):991–9.PubMedCrossRef
380.
Pequignot R, Tzourio C, Peres K, Ancellin ML, Perier MC, Ducimetiere P, et al. Depressive symptoms, antidepressants and disability and future coronary heart disease and stroke events in older adults: the Three City study. Eur J Epidemiol. 2013;28(3):249–56.PubMedCrossRef
381.
Rahman I, Humphreys K, Bennet AM, Ingelsson E, Pedersen NL, Magnusson PKE. Clinical depression, antidepressant use and risk of future cardiovascular disease. Eur J Epidemiol. 2013;28(7):589–95.PubMedCrossRef
382.
Smith GD, Hypponen E, Moldovan M, Power C. Death of siblings in childhood and subsequent mortality: prospective observational study. Eur J Epidemiol. 2014;29(11):859–61.CrossRef
383.
Timm S, Svanes C, Janson C, Sigsgaard T, Johannessen A, Gislason T, et al. Place of upbringing in early childhood as related to inflammatory bowel diseases in adulthood: a population-based cohort study in Northern Europe. Eur J Epidemiol. 2014;29(6):429–37.PubMedCentralPubMedCrossRef
384.
Westerlund A, Bellocco R, Sundstrom J, Adami HO, Akerstedt T, Lagerros YT. Sleep characteristics and cardiovascular events in a large Swedish cohort. Eur J Epidemiol. 2013;28(6):463–73.PubMedCrossRef
385.
Duijts L, Reiss I, Brusselle G, de Jongste J. Early origins of chronic obstructive lung diseases across the life course. Eur J Epidemiol. 2014;29(12):871–85.PubMedCrossRef
386.
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–38.PubMedCrossRef
387.
MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CPM, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respiratory J. 2005;26(4):720–35.CrossRef
388.
Hancock DB, Eijgelsheim M, Wilk JB, Gharib SA, Loehr LR, Marciante KD, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45–52.PubMedCentralPubMedCrossRef
389.
Artigas MS, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang WB, et al. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet. 2011;43(11):1082–90.PubMedCentralCrossRef
390.
Loth DW, Artigas MS, Gharib SA, Wain LV, Franceschini N, Koch B, et al. Genome-wide association analysis identifies six new loci associated with forced vital capacity. Nat Genet. 2014;46(7):669–77.PubMedCentralPubMedCrossRef
391.
Brusselle G. Why doesn’t reducing exacerbations decrease COPD mortality? Lancet Respir Med. 2014;2(9):681–3.PubMedCrossRef
392.
van Durme YM, Verhamme KM, Stijnen T, van Rooij FJ, Van Pottelberge GR, Hofman A, et al. Prevalence, incidence, and lifetime risk for the development of COPD in the elderly: the Rotterdam Study. Chest. 2009;135(2):368–77.PubMedCrossRef
393.
Lahousse L, van den Bouwhuijsen QJA, Loth DW, Joos GF, Hofman A, Witteman JCM, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med. 2013;187(1):58–64.PubMedCrossRef
394.
Lahousse L, Vernooij MW, Darweesh SKL, Akoudad S, Loth DW, Joos GF, et al. Chronic obstructive pulmonary disease and cerebral microbleeds. The Rotterdam Study. Am J Respir Crit Care Med. 2013;188(7):783–8.PubMedCrossRef
395.
Lahousse L, Verlinden VJA, van der Geest JN, Joos GF, Hofman A, Stricker BHC, et al. Gait patterns in COPD: the Rotterdam Study. Eur Respir J. 2015;19:2015.
396.
Lahousse L, Niemeijer MN, van den Berg ME, Rijnbeek PR, Joos GF, Hofman A, et al. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam Study. Eur Heart J. 2015;36(27):1754–61.
397.
Loth DW, Brusselle GG, Lahousse L, Hofman A, Leufkens HGM, Stricker BH. β-adrenoceptor blockers and pulmonary function in the general population: the Rotterdam Study. Br J Clin Pharmacol. 2014;77(1):190–200.PubMedCentralPubMedCrossRef
398.
Luczynska A, Logan C, Nieters A, Elgizouli M, Schottker B, Brenner H, et al. Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm birth cohort. Eur J Epidemiol. 2014;29(8):585–94.PubMedCrossRef
399.
MacIntyre EA, Carlsten C, MacNutt M, Fuertes E, Melen E, Tiesler CMT, et al. Traffic, asthma and genetics: combining international birth cohort data to examine genetics as a mediator of traffic-related air pollution’s impact on childhood asthma. Eur J Epidemiol. 2013;28(7):597–606.PubMedCrossRef
400.
Gnagnarella P, Maisonneuve P, Bellomi M, Rampinelli C, Bertolotti R, Spaggiari L, et al. Nutrient intake and nutrient patterns and risk of lung cancer among heavy smokers: results from the COSMOS screening study with annual low-dose CT. Eur J Epidemiol. 2013;28(6):503–11.PubMedCrossRef
401.
Loth DW, Ittermann T, Lahousse L, Hofman A, Leufkens HGM, Brusselle GG, et al. Normal spirometry values in healthy elderly: the Rotterdam Study. Eur J Epidemiol. 2013;28(4):329–34.PubMedCrossRef
402.
Mohner M, Kersten N, Gellissen J. Diesel motor exhaust and lung cancer mortality: reanalysis of a cohort study in potash miners. Eur J Epidemiol. 2013;28(2):159–68.PubMedCrossRef
403.
Brostrom EB, Akre O, Katz-Salamon M, Jaraj D, Kaijser M. Obstructive pulmonary disease in old age among individuals born preterm. Eur J Epidemiol. 2013;28(1):79–85.PubMedCrossRef
404.
Kreiner-Moller E, Medina-Gomez C, Uitterlinden AG, Rivadeneira F, Estrada K. Improving accuracy of rare variant imputation with a two-step imputation approach. Eur J Hum Genet. 2015;23(3):395–400.PubMedCrossRef
405.
Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, Abdellaoui A, et al. The genome of the Netherlands: design, and project goals. Eur J Hum Genet. 2014;22(2):221–7.PubMedCentralPubMedCrossRef
406.
Westra HJ, Franke L. From genome to function by studying eQTLs. Biochim Biophys Acta. 2014;1842(10):1896–902.PubMedCrossRef
407.
Huan T, Esko T, Peters MJ, Pilling LC, Schramm K, Schurmann C, et al. A meta-analysis of gene expression signatures of blood pressure and hypertension. PLoS Genet. 2015;11(3):e1005035.PubMedCentralPubMedCrossRef
408.
Aleksandrova K, Jenab M, Bueno-de-Mesquita HB, Fedirko V, Kaaks R, Lukanova A, et al. Biomarker patterns of inflammatory and metabolic pathways are associated with risk of colorectal cancer: results from the European prospective investigation into cancer and nutrition (EPIC). Eur J Epidemiol. 2014;29(4):261–75.PubMedCrossRef
409.
Altmaier E, Fobo G, Heier M, Thorand B, Meisinger C, Romisch-Margl W, et al. Metabolomics approach reveals effects of antihypertensives and lipid-lowering drugs on the human metabolism. Eur J Epidemiol. 2014;29(5):325–36.PubMedCentralPubMedCrossRef
410.
Baltar VT, Xun WW, Johansson M, Ferrari P, Chuang SC, Relton C, et al. A structural equation modelling approach to explore the role of B vitamins and immune markers in lung cancer risk. Eur J Epidemiol. 2013;28(8):677–88.PubMedCrossRef
411.
Broer L, Lill CM, Schuur M, Amin N, Roehr JT, Bertram L, et al. Distinguishing true from false positives in genomic studies: p values. Eur J Epidemiol. 2013;28(2):131–8.PubMedCrossRef
412.
Broer L, Raschenberger J, Deelen J, Mangino M, Codd V, Pietilainen KH, et al. Association of adiponectin and leptin with relative telomere length in seven independent cohorts including 11,448 participants. Eur J Epidemiol. 2014;29(9):629–38.PubMedCrossRef
413.
Ege MJ, Strachan DP. Comparisons of power of statistical methods for gene-environment interaction analyses. Eur J Epidemiol. 2013;28(10):785–97.PubMedCrossRef
414.
Lind L, Elmstahl S, Bergman E, Englund M, Lindberg E, Michaelsson K, et al. EpiHealth: a large population-based cohort study for investigation of gene-lifestyle interactions in the pathogenesis of common diseases. Eur J Epidemiol. 2013;28(2):189–97.PubMedCrossRef
415.
Mitrova E, Kosorinova D, Gajdos M, Sebekova K, Tomekova I. A pilot study of a genetic CJD risk factor (E200 K) in the general Slovak population. Eur J Epidemiol. 2014;29(8):595–7.PubMedCrossRef
416.
Raoult D, Foti B, Aboudharam G. Historical and geographical parallelism between the incidence of dental caries, Streptococcus mutans and sugar intake. Eur J Epidemiol. 2013;28(8):709–10.PubMedCentralPubMedCrossRef
417.
Rydell M, Granath F, Cnattingius S, Magnusson C, Galanti MR. In-utero exposure to maternal smoking is not linked to tobacco use in adulthood after controlling for genetic and family influences: a Swedish sibling study. Eur J Epidemiol. 2014;29(7):499–506.PubMedCrossRef
418.
Sjolander A, Lee W, Kallberg H, Pawitan Y. Bounds on sufficient–cause interaction. Eur J Epidemiol. 2014;29(11):813–20.PubMedCrossRef
419.
Stang A, Poole C. The researcher and the consultant: a dialogue on null hypothesis significance testing. Eur J Epidemiol. 2013;28(12):939–44.PubMedCrossRef
420.
Stang A, Poole C. The researcher and the consultant: a dialogue on null hypothesis significance testing (vol 28, pg 939, 2013). Eur J Epidemiol. 2014;29(3):225.CrossRef
421.
Steenstrup T, Hjelmborg JVB, Mortensen LH, Kimura M, Christensen K, Aviv A. Leukocyte telomere dynamics in the elderly. Eur J Epidemiol. 2013;28(2):181–7.PubMedCentralPubMedCrossRef
422.
Thompson CA, Zhang ZF, Arah OA. Competing risk bias to explain the inverse relationship between smoking and malignant melanoma. Eur J Epidemiol. 2013;28(7):557–67.PubMedCrossRef
423.
VanderWeele TJ. Unmeasured confounding and hazard scales: sensitivity analysis for total, direct, and indirect effects. Eur J Epidemiol. 2013;28(2):113–7.PubMedCentralPubMedCrossRef
424.
Verhulst S, Aviv A, Benetos A, Berenson GS, Kark JD. Do leukocyte telomere length dynamics depend on baseline telomere length? An analysis that corrects for ‘regression to the mean’. Eur J Epidemiol. 2013;28(11):859–66.PubMedCrossRef
425.
Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013;34(38):2940–8.PubMedCrossRef
426.
Postmus I, Trompet S, Deshmukh HA, Barnes MR, Li X, Warren HR, et al. Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins. Nat Commun. 2014;5:5068.PubMedCentralPubMedCrossRef
427.
de Keyser CE, Eijgelsheim M, Hofman A, Sijbrands EJ, Maitland-van der Zee AH, van Duijn CM, et al. Single nucleotide polymorphisms in genes that are associated with a modified response to statin therapy: the Rotterdam Study. Pharmacogenomics J. 2011;11(1):72–80.PubMedCrossRef
428.
de Keyser CE, Becker ML, Uitterlinden AG, Hofman A, Lous JJ, Elens L, et al. Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study. Pharmacogenomics. 2013;14(11):1295–304.PubMedCrossRef
429.
de Keyser CE, Becker ML, Hofman A, Lous JJ, Uitterlinden AG, Visser LE, et al. The rs13064411 polymorphism in the WDR52 gene, associated with PCSK9 levels, modifies statin-induced changes in serum total and LDL cholesterol levels. Pharmacogenet Genomics. 2015;25(3):134–42.PubMedCrossRef
430.
Leusink M, de Keyser CE, Onland-Moret NC, Hofman A, Visser LE, Stricker BH, et al. No association between CYP3A4*22 and statin effectiveness in reducing the risk for myocardial infarction. Pharmacogenomics. 2014;15(11):1471–7.PubMedCrossRef
431.
de Keyser CE, Peters BJ, Becker ML, Visser LE, Uitterlinden AG, Klungel OH, et al. The SLCO1B1 c.521T>C polymorphism is associated with dose decrease or switching during statin therapy in the Rotterdam Study. Pharmacogenet Genomics. 2014;24(1):43–51.PubMedCrossRef
432.
de Keyser CE, de Lima FV, de Jong FH, Hofman A, de Rijke YB, Uitterlinden AG, et al. Use of statins is associated with lower serum total and non-sex hormone-binding globulin-bound testosterone levels in male participants of the Rotterdam Study. Eur J Endocrinol. 2015;173(2):155–65.
433.
Niemeijer MN, van den Berg ME, Leening MJ, Hofman A, Franco OH, Deckers JW, et al. Declining incidence of sudden cardiac death from 1990–2010 in a general middle-aged and elderly population: The Rotterdam Study. Heart Rhythm. 2015;12(1):123–9.PubMedCrossRef
434.
Arking DE, Pulit SL, Crotti L, van der Harst P, Munroe PB, Koopmann TT, et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46(8):826–36.PubMedCentralPubMedCrossRef
435.
Noordam R, van den Berg ME, Niemeijer MN, Aarts N, Leening MJ, Deckers JW, et al. Assessing prolongation of the heart rate corrected QT interval in users of tricyclic antidepressants: advice to use Fridericia rather than Bazett’s correction. J Clin Psychopharmacol. 2015;35(3):260–5.PubMedCrossRef
436.
Maljuric NM, Noordam R, Aarts N, Niemeijer MN, van den Berg ME, Hofman A, et al. Use of selective serotonin reuptake inhibitors and the heart-rate corrected QT interval in a real-life setting: the population-based Rotterdam Study. Br J Clin Pharmacol. 2015. doi:10.​1111/​bcp.​12681.
437.
Niemeijer MN, van den Berg ME, Eijgelsheim M, van Herpen G, Stricker BH, Kors JA, et al. Short-term QT variability markers for the prediction of ventricular arrhythmias and sudden cardiac death: a systematic review. Heart. 2014;100(23):1831–6.PubMedCrossRef
438.
Krijthe BP, Heeringa J, Hofman A, Franco OH, Stricker BH. Non-steroidal anti-inflammatory drugs and the risk of atrial fibrillation: a population-based follow-up study. BMJ Open. 2014;4(4):e004059.PubMedCentralPubMedCrossRef
439.
Krijthe BP, Heeringa J, Kors JA, Hofman A, Franco OH, Witteman JC, et al. Serum potassium levels and the risk of atrial fibrillation: the Rotterdam Study. Int J Cardiol. 2013;168(6):5411–5.PubMedCrossRef
440.
Lubitz SA, Lunetta KL, Lin H, Arking DE, Trompet S, Li G, et al. Novel genetic markers associate with atrial fibrillation risk in Europeans and Japanese. J Am Coll Cardiol. 2014;63(12):1200–10.PubMedCentralPubMedCrossRef
441.
Aarts N, Noordam R, Hofman A, Tiemeier H, Stricker BH, Visser LE. Utilization patterns of antidepressants between 1991 and 2011 in a population-based cohort of middle-aged and elderly. Eur Psychiatry. 2014;29(6):365–70.PubMedCrossRef
442.
Noordam R, Aarts N, Hofman A, van Schaik RH, Stricker BH, Visser LE. Association between genetic variation in the ABCB1 gene and switching, discontinuation, and dosage of antidepressant therapy: results from the Rotterdam Study. J Clin Psychopharmacol. 2013;33(4):546–50.PubMedCrossRef
443.
Aarts N, Akoudad S, Noordam R, Hofman A, Ikram MA, Stricker BH, et al. Inhibition of serotonin reuptake by antidepressants and cerebral microbleeds in the general population. Stroke. 2014;45(7):1951–7.PubMedCrossRef
444.
Akoudad S, Darweesh SK, Leening MJ, Koudstaal PJ, Hofman A, van der Lugt A, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population. Stroke. 2014;45(11):3436–9.PubMedCrossRef
445.
Darweesh SK, Leening MJ, Akoudad S, Loth DW, Hofman A, Ikram MA, et al. Clopidogrel use is associated with an increased prevalence of cerebral microbleeds in a stroke-free population: the Rotterdam Study. J Am Heart Assoc. 2013;2(5):e000359.PubMedCentralPubMedCrossRef
446.
van Blijderveen JC, Verhamme KM, Zietse R, Visser LE, Romio SA, Buhre PN, et al. Overanticoagulation is associated with renal function decline. J Nephrol. 2013;26(4):691–8.PubMedCrossRef
447.
Rodenburg EM, Visser LE, Hoorn EJ, Ruiter R, Lous JJ, Hofman A, et al. Thiazides and the risk of hypokalemia in the general population. J Hypertens. 2014;32(10):2092–7 discussion 7.PubMedCrossRef
448.
Levin D, Bell S, Sund R, Hartikainen SA, Tuomilehto J, Pukkala E, et al. Pioglitazone and bladder cancer risk: a multipopulation pooled, cumulative exposure analysis. Diabetologia. 2015;58(3):493–504.PubMedCrossRef
449.
Lundby A, Rossin EJ, Steffensen AB, Acha MR, Newton-Cheh C, Pfeufer A, et al. Annotation of loci from genome-wide association studies using tissue-specific quantitative interaction proteomics. Nat Methods. 2014;11(8):868–74.PubMedCentralPubMedCrossRef
450.
Sitlani CM, Rice KM, Lumley T, McKnight B, Cupples LA, Avery CL, et al. Generalized estimating equations for genome-wide association studies using longitudinal phenotype data. Stat Med. 2015;34(1):118–30.PubMedCrossRef
451.
Noordam R, Direk N, Sitlani CM, Aarts N, Tiemeier H, Hofman A, et al. Identifying genetic loci associated with antidepressant drug response with drug–gene interaction models in a population-based study. J Psychiatr Res. 2015;62:31–7.PubMedCrossRef
452.
Stricker BH, Stijnen T. Analysis of individual drug use as a time-varying determinant of exposure in prospective population-based cohort studies. Eur J Epidemiol. 2010;25(4):245–51.PubMedCentralPubMedCrossRef
453.
de Keyser CE, Leening MJ, Romio SA, Jukema JW, Hofman A, Ikram MA, et al. Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study. Eur J Epidemiol. 2014;29(11):841–50.PubMedCrossRef
454.
Ali MS, Groenwold RHH, Pestman WR, Belitser SV, Hoes AW, de Boer A, et al. Time-dependent propensity score and collider-stratification bias: an example of beta(2)-agonist use and the risk of coronary heart disease. Eur J Epidemiol. 2013;28(4):291–9.CrossRef
455.
Been JV, Sheikh A. Gestational age misclassification and its effect on disease outcomes after preterm birth. Eur J Epidemiol. 2013;28(6):525–6.PubMedCrossRef
456.
Bless PJ, Schmutz C, Suter K, Jost M, Hattendorf J, Mausezahl-Feuz M, et al. A tradition and an epidemic: determinants of the campylobacteriosis winter peak in Switzerland. Eur J Epidemiol. 2014;29(7):527–37.PubMedCentralPubMedCrossRef
457.
Chang ET, Boffetta P, Adami HO, Cole P, Mandel JS. A critical review of the epidemiology of agent orange/TCDD and prostate cancer. Eur J Epidemiol. 2014;29(10):667–723.PubMedCentralPubMedCrossRef
458.
Crump C, Sundquist J, Sieh W, Winkleby MA, Sundquist K. Perinatal risk factors for Wilms tumor in a Swedish national cohort. Eur J Epidemiol. 2014;29(3):191–7.PubMedCentralPubMedCrossRef
459.
Edgren G, Lagiou P, Trichopoulos D, Adami HO. Screening, case finding or primary cancer prevention in the developing world? Eur J Epidemiol. 2013;28(4):287–90.PubMedCrossRef
460.
Galeotti F, Massari M, D’Alessandro R, Beghi E, Chio A, Logroscino G, et al. Risk of Guillain–Barre, syndrome after 2010–2011 influenza vaccination. Eur J Epidemiol. 2013;28(5):433–44.PubMedCentralPubMedCrossRef
461.
de Groot MCH, Klungel OH, Leufkens HGM, van Dijk L, Grobbee DE, van de Garde EMW. Sources of heterogeneity in case–control studies on associations between statins, ACE-inhibitors, and proton pump inhibitors and risk of pneumonia. Eur J Epidemiol. 2014;29(10):767–75.PubMedCrossRef
462.
Ivkovic V, Karanovic S, Prlic MF, Misic M, Kos J, Juric D, et al. Is herbal tea consumption a factor in endemic nephropathy? Eur J Epidemiol. 2014;29(3):221–4.PubMedCrossRef
463.
Lai SW, Liao KF, Lai HC, Muo CH, Sung FC, Chen PC. Statin use and risk of hepatocellular carcinoma. Eur J Epidemiol. 2013;28(6):485–92.PubMedCrossRef
464.
Ludvigsson JF, Zugna D, Cnattingius S, Richiardi L, Ekbom A, Ortqvist A, et al. Influenza H1N1 vaccination and adverse pregnancy outcome. Eur J Epidemiol. 2013;28(7):579–88.PubMedCrossRef
465.
Nezvalova-Henriksen K, Spigset O, Nordeng H. Triptan safety during pregnancy: a Norwegian population registry study. Eur J Epidemiol. 2013;28(9):759–69.PubMedCrossRef
466.
Rezaeian M. Wars versus SARS: Are epidemiological studies biased? Eur J Epidemiol. 2014;29(6):453–4.PubMedCrossRef
467.
Smedts HPM, de Jonge L, Bandola SJG, Baardman ME, Bakker MK, Stricker BHC, et al. Early pregnancy exposure to antihistamines and risk of congenital heart defects: results of two case-control studies. Eur J Epidemiol. 2014;29(9):653–61.PubMedCrossRef
468.
Stang A, Kaab-Sanyal V, Hense HW, Becker N, Kuss O. Effect of mammography screening on surgical treatment for breast cancer: a nationwide analysis of hospitalization rates in Germany 2005–2009. Eur J Epidemiol. 2013;28(8):689–96.PubMedCrossRef
469.
van der Lijn F, den Heijer T, Breteler MM, Niessen WJ. Hippocampus segmentation in MR images using atlas registration, voxel classification, and graph cuts. Neuroimage. 2008;43(4):708–20.PubMedCrossRef
470.
Vrooman HA, Cocosco CA, van der Lijn F, Stokking R, Ikram MA, Vernooij MW, et al. Multi-spectral brain tissue segmentation using automatically trained k-Nearest-Neighbor classification. Neuroimage. 2007;37(1):71–81.PubMedCrossRef
471.
den Heijer T, van der Lijn F, Koudstaal PJ, Hofman A, van der Lugt A, Krestin GP, et al. A 10-year follow-up of hippocampal volume on magnetic resonance imaging in early dementia and cognitive decline. Brain. 2010;133(Pt 4):1163–72.CrossRef
472.
Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Vrooman HA, Hofman A, et al. Total cerebral blood flow and total brain perfusion in the general population: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(2):412–9.PubMedCrossRef
473.
Poels MM, Ikram MA, Vernooij MW, Krestin GP, Hofman A, Niessen WJ, et al. Total cerebral blood flow in relation to cognitive function: the Rotterdam Scan Study. J Cereb Blood Flow Metab. 2008;28(10):1652–5.PubMedCrossRef
474.
Zonneveld HI, Loehrer EA, Hofman A, Niessen WJ, van der Lugt A, Krestin GP, et al. The bidirectional association between reduced cerebral blood flow and brain atrophy in the general population. J Cereb Blood Flow Metab. 2015. doi:10.​1038/​jcbfm.​2015.​157.
475.
Vernooij MW, Ikram MA, Wielopolski PA, Krestin GP, Breteler MM, van der Lugt A. Cerebral microbleeds: accelerated 3D T2*-weighted GRE MR imaging versus conventional 2D T2*-weighted GRE MR imaging for detection. Radiology. 2008;248(1):272–7.PubMedCrossRef
476.
Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke. 2010;41(10 Suppl):S103–6.PubMedCrossRef
477.
Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology. 2008;70(14):1208–14.PubMedCrossRef
478.
Poels MM, Ikram MA, van der Lugt A, Hofman A, Krestin GP, Breteler MM, et al. Incidence of cerebral microbleeds in the general population: the Rotterdam Scan Study. Stroke. 2011;42(3):656–61.PubMedCrossRef
479.
Lovelock CE, Cordonnier C, Naka H, Al-Shahi Salman R, Sudlow CL, Edinburgh Stroke Study G, et al. Antithrombotic drug use, cerebral microbleeds, and intracerebral hemorrhage: a systematic review of published and unpublished studies. Stroke. 2010;41(6):1222–8.PubMedCrossRef
480.
Vernooij MW, Haag MD, van der Lugt A, Hofman A, Krestin GP, Stricker BH, et al. Use of antithrombotic drugs and the presence of cerebral microbleeds: the Rotterdam Scan Study. Arch Neurol. 2009;66(6):714–20.PubMedCrossRef
481.
Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, Niessen WJ, Greenberg SM, et al. Cerebral microbleeds are associated with the progression of ischemic vascular lesions. Cerebrovasc Dis. 2014;37(5):382–8.PubMedCrossRef
482.
Akoudad S, Portegies ML, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, et al. Cerebral microbleeds are associated with an increased risk of stroke: the Rotterdam Study. Circulation. 2015;132(6):509–16.
483.
Vernooij MW, de Groot M, van der Lugt A, Ikram MA, Krestin GP, Hofman A, et al. White matter atrophy and lesion formation explain the loss of structural integrity of white matter in aging. Neuroimage. 2008;43(3):470–7.PubMedCrossRef
484.
Vernooij MW, Ikram MA, Vrooman HA, Wielopolski PA, Krestin GP, Hofman A, et al. White matter microstructural integrity and cognitive function in a general elderly population. Arch Gen Psychiatry. 2009;66(5):545–53.PubMedCrossRef
485.
de Groot M, Vernooij MW, Klein S, Ikram MA, Vos FM, Smith SM, et al. Improving alignment in tract-based spatial statistics: evaluation and optimization of image registration. Neuroimage. 2013;1(76):400–11.CrossRef
486.
de Groot M, Ikram MA, Akoudad S, Krestin GP, Hofman A, van der Lugt A, et al. Tract-specific white matter degeneration in aging: the Rotterdam Study. Alzheimers Dement. 2015;11(3):321–30.PubMedCrossRef
487.
Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15(4):827–32.PubMedCrossRef
488.
Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, et al. Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam Study. Atherosclerosis. 2007;193(2):408–13.PubMedCrossRef
489.
Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, et al. Risk factors for coronary, aortic arch and carotid calcification. The Rotterdam Study. J Hum Hypertens. 2010;24(2):86–92.PubMedCrossRef
490.
Elias-Smale SE, Odink AE, Wieberdink RG, Hofman A, Hunink MG, Krestin GP, et al. Carotid, aortic arch and coronary calcification are related to history of stroke: the Rotterdam Study. Atherosclerosis. 2010;212(2):656–60.PubMedCrossRef
491.
Bos D, Portegies ML, van der Lugt A, Bos MJ, Koudstaal PJ, Hofman A, et al. Intracranial carotid artery atherosclerosis and the risk of stroke in whites: the Rotterdam Study. JAMA Neurol. 2014;71(4):405–11.PubMedCrossRef
492.
Takaya N, Yuan C, Chu B, Saam T, Underhill H, Cai J, et al. Association between carotid plaque characteristics and subsequent ischemic cerebrovascular events: a prospective assessment with MRI-initial results. Stroke. 2006;37(3):818–23.PubMedCrossRef
493.
Yuan C, Mitsumori LM, Ferguson MS, Polissar NL, Echelard D, Ortiz G, et al. In vivo accuracy of multispectral magnetic resonance imaging for identifying lipid-rich necrotic cores and intraplaque hemorrhage in advanced human carotid plaques. Circulation. 2001;104(17):2051–6.PubMedCrossRef
494.
Trial North American Symptomatic Carotid Endarterectomy. Methods, patient characteristics, and progress. Stroke. 1991;22(6):711–20.CrossRef
495.
Selwaness M, van den Bouwhuijsen Q, van Onkelen RS, Hofman A, Franco OH, van der Lugt A, et al. Atherosclerotic plaque in the left carotid artery is more vulnerable than in the right. Stroke. 2014;45(11):3226–30.PubMedCrossRef
496.
van den Bouwhuijsen QJ, Bos D, Ikram MA, Hofman A, Krestin GP, Franco OH, et al. Coexistence of calcification, intraplaque hemorrhage and lipid core within the asymptomatic atherosclerotic carotid plaque: the Rotterdam Study. Cerebrovasc Dis. 2015;39(5–6):319–24.PubMedCrossRef
497.
Akoudad S, Ikram MA, Koudstaal PJ, Hofman A, van der Lugt A, Vernooij MW. Cerebral microbleeds and the risk of mortality in the general population. Eur J Epidemiol. 2013;28(10):815–21.PubMedCrossRef
498.
Hou LF, Lloyd-Jones DM, Ning HY, Huffman MD, Fornage M, He K, et al. White blood cell count in young adulthood and coronary artery calcification in early middle age: coronary artery risk development in young adults (CARDIA) study. Eur J Epidemiol. 2013;28(9):735–42.PubMedCrossRef
499.
Wahl S, Mohlenkamp S, Erbel R, Moebus S, Andrich S, Stang A, et al. Screening results for subclinical coronary artery calcification in asymptomatic individuals in relation to a detailed parental history of premature coronary heart disease. Eur J Epidemiol. 2013;28(4):301–10.PubMedCrossRef
500.
White T, El Marroun H, Nijs I, Schmidt M, van der Lugt A, Wielopolki PA, et al. Pediatric population-based neuroimaging and the generation R study: the intersection of developmental neuroscience and epidemiology. Eur J Epidemiol. 2013;28(1):99–111.PubMedCrossRef
501.
Smits C, Kapteyn TS, Houtgast T. Development and validation of an automatic speech-in-noise screening test by telephone. Int J Audiol. 2004;43(1):15–28.PubMedCrossRef
502.
Weber KP, Aw ST, Todd MJ, McGarvie LA, Curthoys IS, Halmagyi GM. Head impulse test in unilateral vestibular loss: vestibulo-ocular reflex and catch-up saccades. Neurology. 2008;70(6):454–63.PubMedCrossRef
503.
Cox RM, Alexander GC. The international outcome inventory for hearing aids (IOI-HA): psychometric properties of the English version. Int J Audiol. 2002;41(1):30–5.PubMedCrossRef
504.
Newman CW, Sandridge SA, Bolek L. Development and psychometric adequacy of the screening version of the tinnitus handicap inventory. Otol Neurotol. 2008;29(3):276–81.PubMedCrossRef
505.
506.
Gurgel RK, Ward PD, Schwartz S, Norton MC, Foster NL, Tschanz JT. Relationship of hearing loss and dementia: a prospective, population-based study. Otol Neurotol. 2014;35(5):775–81.PubMedCentralPubMedCrossRef
507.
Lin FR, Ferrucci L, Metter EJ, An Y, Zonderman AB, Resnick SM. Hearing loss and cognition in the Baltimore longitudinal study of aging. Neuropsychology. 2011;25(6):763–70.PubMedCentralPubMedCrossRef
508.
Metadata
Title
The Rotterdam Study: 2016 objectives and design update
Authors
Albert Hofman
Guy G. O. Brusselle
Sarwa Darwish Murad
Cornelia M. van Duijn
Oscar H. Franco
André Goedegebure
M. Arfan Ikram
Caroline C. W. Klaver
Tamar E. C. Nijsten
Robin P. Peeters
Bruno H. Ch. Stricker
Henning W. Tiemeier
André G. Uitterlinden
Meike W. Vernooij
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
European Journal of Epidemiology / Issue 8/2015
Print ISSN: 0393-2990
Electronic ISSN: 1573-7284
DOI
https://doi.org/10.1007/s10654-015-0082-x

Other articles of this Issue 8/2015

European Journal of Epidemiology 8/2015 Go to the issue

REVIEW

Association of serum total osteocalcin with type 2 diabetes and intermediate metabolic phenotypes: systematic review and meta-analysis of observational evidence

SOCIAL EPIDEMIOLOGY

A Swiss paradox? Higher income inequality of municipalities is associated with lower mortality in Switzerland

MORTALITY

Income inequality, life expectancy and cause-specific mortality in 43 European countries, 1987–2008: a fixed effects study

SOCIAL EPIDEMIOLOGY

Low mortality in the poorest areas of Spain: adults residing in provinces with lower per capita income have the lowest mortality

Abstracts

Healthy Living: The European Congress of Epidemiology, 2015

DIABETES MELLITUS

Secular trends and educational differences in the incidence of type 2 diabetes in Finland, 1972–2007